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Effects of Fe and Se status on GSHPx activity and lipid peroxidation in liver and 
intestinal mucosa were studied. Rats were Se and Fe supplemented ( +Se+Fe), Se-
deficient and Fe-supplemented (-Se+Fe), Se supplemented and Fe overloaded (+Se++Fe) 
by intramuscular injection, or Se deficient and Fe overloaded (-Se++Fe) for 20d. Fe 
overloaded tissues had more Fe, but hemoglobin was unaffected. Liver and mucosal 
GSHPx activity was low in Se-deficient rats. Thiobarbituric acid reactive substances 
(TBARS) were higher in Fe overloaded and -Se++Fe vs +Se++Fe tissues. Mucosal 
TBARS was higher in -Se++Fe rats gavaged with CBrCl3. In experiment 2, Fe overload 
was induced by a 2% carbonyl iron, low-Se diet fed for 2mo, the +Se++Fe and -Se++Fe 
groups. Low Se-, low Fe-diet was fed to rats supplemented with Fe or Fe and Se in the 
water, the -Se+Fe and +Se+Fe controls. Iron overloaded tissues had more Fe. Liver and 
mucosal GSHPx activity was lower in Se-deficient and +Se++Fe vs +Se+Fe rats. 
TBARS was higher in Fe overloaded, -Se++Fe vs +Se++Fe, and CBrCl3 tissues. 
Hemoglobin and serum Fe were lower in the -Se++Fe group. In experiment 3, low-Se, 
low-Fe diet was fed for 20d, the -Se-Fe, +Se-Fe, -Se+Fe and +Se+Fe groups. Mucosal 
Fe w s 1 wer i the Fe-deficient rats. Cytochrome P-450 and GSHPx activities were 
ix 
lower and TBARS was higher in Se-deficient tissues. In experiment 4, the +Se+Fe, +Se-
Fe, -Se+Fe, -Se-Fe, +Se++Fe, and -Se++Fe groups treated as in experiment 3. Iron 
overloaded tissues had more Fe and TBARS, but hemoglobin and serum Fe were 
unaffected. GSHPx and Cytochrome P-450 activities were lower in Se-deficient and in 
+Se++Fe vs +Se+Fe rats. CBrCl3 did not affect TBARS. 
High TBARS occurred in liver and mucosa of Fe overloaded rats. Chronic Fe 
overload was required to reduce liver and mucosal GSHPx activity. The combination of 
Se deficiency and Fe overload caused very high TBARS. Low oral CBrCl3 doses 
elevated mucosal TBARS, a first report of extrahepatic action of CBrCl3 in vivo. Iron 




Lipid peroxidation has been growing in medical importance. Several diseases and 
toxic cell injuries have been associated with free-radical disturbances. These diseases 
include inflammation, rheumatoid arthritis, atherosclerosis, alcoholism, Fe overload of the 
liver, toxic liver injury (such as that related to bromotrichloromethane), tumor promotion, 
some examples of chemical carcinogenesis, reperfusion injury, and cirrhosis (Slater, 
1987). 
Nutritional disorders associated with free-radical disturbances can be due to a 
deficient intake of a required nutrient such as vitamin E or selenium (Se), a constituent of 
the enzyme glutathione peroxidase (GSHPx); both have protective antioxidant effects. A 
deficient intake of Fe can increase the amount of unsaturated lipids in the cellular 
membrane (Larkin et al., 1986) and can also induce fatty livers (Bartholmey and 
Sherman, 1985), conditions that favor lipid peroxidation of the cell in different organs and 
in liver. Iron deficiency can also lower the enzymatic activity of GSHPx and catalase 
(Rodvien et al., 1974; MacDougall, 1972), both important lines of cellular defense against 
lipid peroxidation. Nutritional disorders can also be due to excess intake of substances, 
such as transitional metals like iron (Fe), that can stimulate free-radical production. Iron 
overload can also lower the hepatic Se-dependent GSHPx activity (Reffet et al., 1986; Lee 
et al., 1981). 
Selenium deficiency and, more recently, high Fe stores have been related to an 
increased incidence of cancers. Epidemiological evidence shows an inverse relationship 
between Se intake and certain forms of cancer in humans, especially intestinal and breast 
cancers. Some studies also show an inverse association between cancer incidence and Se 
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concentration in local forage plants and in human blood. It is possible that Se deficiency 
does not cause cancer but increases susceptibility to cancer development (Jacobs, 1977; 
Schrauzer, 1976; Knekt et al., 1988). 
Several studies support the hypothesis that high body Fe stores increase the risk of 
cancer in humans (Selby and Friedman, 1988). It ~as found that hepatocellular 
carcinoma is one of the two leading causes of death in patients with hereditary 
hemochromatosis (Britton et al., 1987). Hemochromatosis is a disorder of Fe 
metabolism in which massive amounts of Fe are deposited in various organs. Full 
expression of the disease occurs in homozygotes, and body Fe stores are abnormal in a 
significant portion of heterozygotes (Edwards et al., 1982). It is estimated that about one 
in ten individuals are heterozygous for the disease (Skikne and Cook, 1987). 
Lipid peroxidation is a free-radical-mediated process that can result in acute 
cellular injury, especially if the normal protective mechanisms of the cell are reduced. On 
the other hand, lipid peroxidation itself and some of its by-products are potential initiators 
and promoters of cancer (Vaca et al., 1988; Weinstein, 1981). 
Experimental evidence suggests that Fe is involved in the initiation of lipid 
peroxidation. It is generally accepted that Fe may serve as a catalyst for the formation of 
the hydroxyl radical (·OH), which initiates lipid peroxidation (Minotti and Aust, 1987). 
Glutathione peroxidase is an important line of cellular defense against lipid 
peroxidation (Rotruck et al., 1973; Flohe et al., 1973). It has central importance in 
protecting against the pro-oxidative consequences of metabolic activation of oxygen 
(generation of ·OH) via the reduction of H202 in the cell. It also catalyzes the reduction of 
organic hydroperoxides formed from unsaturated fatty acids, blocking the subsequent free-
radical formation (Mills, 1957; Little and O'Brien, 1968). However, no direct 
relationship between lowered Se-dependent GSHPx protection against lipid peroxidation 
an cancer initiation or promotion has been established. 
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In several tissues including liver, a percentage of the total GSHPx is Se-
independent and can be induced during Se deficiency; in contrast, no Se-independent 
GSHPx is found in the rat intestine (Levander, 1982). Due to the fast cell turnover rate of 
this tissue and to its dependence on Se from the diet and not from body stores of the 
element (Pascoe et al., 1983), the intestinal GSHPx protection against free-radicals 
damage could be seriously compromised by an Se-deficient diet. The fast turnover rate of 
cells in the intestinal tract also makes this epithelium particularly susceptible to the action 
of free radicals. This is probably true also for mutagens and carcinogens, which can 
originate from the diet and exert their toxicity through the generation of oxygen radicals 
(Ames, 1983). The role of Fe in mediating free-radical damage to gastric mucosal cells 
has been documented (Hiraishi et al., 1988); it is also known that Fe deprivation might 
affect most severely those tissues that have a rapid growth and rate of cell division or 
tissues with high metabolic rates (Pascoe et al., 1983). 
In the present study, the in vivo effect of Se deficiency (bdependently and also in 
combination with Fe overload or with Fe deficiency) on the livers and intestines of rats 
was investigated. Four parameters were evaluated: 1) liver cytochrome P-450 activity, 2) 
hepatic and intestinal Se-dependent GSHPx activity, 3) hepatic and intestinal lipid 
peroxidation, and 4) total Fe at the liver and at the intestine, 
Theoretically, these parameters have the potential to influence, individually and in 
combined modes, the development of intestinal and hepatic cancer. They could also 
influence other diseases associated with free-radical disturbances. 
Two models of experimental Fe overload induction were used: oral ingestion of 
carbonyl iron, which induces hepatic Fe distribution in a pattern analogous to that seen in 
human hereditary hemochromatosis (in hepatocytes), and intramuscular injections of iron 
dextran, which induce a more homogeneous deposition (in hepatocytes and Kupffer cells) 






Iron overload is a medical problem in a number of disorders commonly called 
hemochromatosis. Hereditary hemochromatosis was once considered to be a rare disease; 
we know now that it is one of the most common autosomal recessive disorders . It is 
estimated that about one in ten individuals in northern Europe, North America, and 
Australia are heterozygous and that 2-3/10,000 people are homozygous (Skikne and 
Cook, 1987). Full expression of the disease occurs in homozygotes, and measurements 
of body-Fe stores are abnormal in a significant portion of heterozygotes (Edwards et al., 
1982). 
Iron overload can result from increased absorption of dietary Fe, by parental 
administration, or both. Although it is clear that certain cases of hemochromatosis are 
secondary to transfusional Fe loading or to a huge dietary excess of Fe, in most cases, the 
disease has been termed idiopathic in origin. 
Iron balance is regulated by controlling Fe absorption. The absorption of Fe is 
reciprocally related to body-Fe stores, so that as stores decline absorption increases and 
vice versa. The biochemical signals influencing rates of Fe absorption and the ultimate 
mechanisms by which the epithelial cells of the intestine absorb Fe are not known. A 
defect in this homeostatic control mechanism seems to be the cause of Fe overload in 
hereditary hemochromatosis (Britton et al., 1987). 
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Hemochromatosis is a disorder of Fe metabolism characterized clinically by 
hepatic cirrhosis, skin pigmentation, arthropathy, cardiomyopathy, and endocrinopathies. 
Most of these clinical findings are the result of organ damage due to the deposition of 
massive amounts of Fe (Edwards et al., 1982). 
Two models of experimental Fe overload induction in rats are generally used: 
intramuscular injections of iron dextran and oral ingestion of dietary carbonyl iron (Dillard 
et al., 1984; Bacon et al., 1986). Carbonyl iron induces Fe distribution in a pattern 
analogous to that seen in human hereditary hemochromatosis (in hepatocytes), while a 
more homogeneous deposition (in hepatocytes and Kupffer cells) has been observed with 
parenteral Fe (Bacon et al., 1986). 
Cancer 
Several studies support the hypothesis that high body-Fe stores increase the risk 
of cancer in humans (Selby and Friedman, 1988) and the increase of overall death rates 
(Stevens et al., 1983). 
It was found that complications of chronic liver disease and hepatocellular 
carcinoma were the two leading causes of death in patients with hereditary 
hemochromatosis. It appears likely that cirrhosis is a prerequisite for the development of 
hepatic cancer in these patients since all liver cancers developed in cirrhotic livers, and 
there are no reports of liver cancer developing in noncirrhotic patients with 
hemochromatosis (Britton et al., 1987). 
Two lines of evidence provide a biologic rationale for the hypothesis. First, Fe 
can catalyze the production of oxygen radicals, and these may be proximate carcinogens. 
Second, Fe may be a limiting nutrient for the growth and development of cancer cells; 




A plethora of evidence from in vivo and in vitro studies suggests that Fe is 
involved in the initiation of lipid peroxidation and may be responsible for the observed 
tissue damage associated with various Fe overload related pathologies (Britton et al., 
1987). 
Mechanisms of action 
Most of our understanding of the pathophysiological effects of excess tissue Fe is 
derived from clinical and/or experimental studies of the effects of Fe on the liver. In 
hereditary hemochromatosis, the liver is the major recipient of the excess absorbed Fe. 
Despite the existent convincing clinical evidence for the hepatotoxicity of excess Fe, the 
specific pathophysiological mechanisms for hepatocyte injury and hepatic fibrosis in 
chronic Fe overload are poorly understood (Britton et al., 1987). 
Several mechanisms whereby excess hepatic Fe causes cellular injury with 
resultant fibrosis and cirrhosis have been proposed. The biochemical form of intracellular 
Fe responsible for initiating these hepatotoxic manifestations is unknown. In conditions 
of Fe overload, the ability of the hepatocyte to maintain Fe in the nontoxic protein-bound 
ferric state may be exceeded, resulting either in small amounts of ferrous Fe or in 
excessive amounts of of low molecular weight chelate Fe in the cytosol (Britton et al., 
1987). Iron in these forms in the presence of available cellular reductants (ascorbate, 
NADPH) may play a catalytic role in the initiation of peroxidative injury to 
polyunsaturated fatty acids of membrane phospholipids of organelles. This results in 
abnormalities of organelle functions, which are dependent on intact organelle membrane 
structure (Minotty and Aust, 1987). Abnormalities in mitochondrial and microsomal 
function along with the possible leakage of hydrolytic lysosomal enzymes from 
peroxidized lysosomal membranes may provide sufficient organelle dysfunction to be 
deleterious to the maintenance of normal cell integrity (Peters et al., 1985). At the present 
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time it is unknown whether any of these functional abnormalities in subcellular organelles 
(lysosomes, mitochondria, microsomes) demonstrated experimentally are 
pathophysiologically significant in producing the chronic liver damage observed in the 
human conditions of Fe overload. 
Another mechanism of liver damage in Fe overload is that proposed by Weintraub 
et al. (1985), in which excess tissue Fe may provide a direct stimulus to collagen 
biosynthesis and lead to the development of fibrosis without invoking preceding Fe-
mediated cellular injury. None of these postulated mechanisms is mutually exclusive, and 
all may be operative concomitantly. Further experimental studies are necessary to 
determine the relative importance of these various proposed mechanisms as they relate to 
the tissue damage seen in patients with Fe overload. 
Animal studies 
Ionic Fe is known to stimulate lipid peroxidation in vitro. Lysosomal fragility has 
been examined in rats fed diet containing elemental carbonyl Fe; increased lysosomal 
fragility correlated with increasing hepatic Fe concentrations (Britton et al., 1987). 
Studies with lysosomes have suggested that the increased membrane fragility is mediated 
by Fe induced peroxidative injury to lysosomal membranes (Mak and Weglicki, 1985; 
O'Connell et al., 1985). Iron induced membrane lipid peroxidation of mitochondria and 
microsomes, leading to functional insufficiency with subsequent cell injury and cell death 
is another mechanism though not mutually exclusive. 
The effect of Fe overload on hepatic mitochondrial oxidative metabolism has been 
studied in rats fed dietary carbonyl iron, and in rats to which Fe was injected. There is 
evidence of Fe-induced lipid peroxidation in hepatic mitochondria and microsomes from 
rats with chronic Fe overload (Bacon et al., 1983). Associated functional abnormalities in 
hepatic mitochondria showed a decrease in respiratory control due to an irreversible 
inhibitory defect in electron transport (Bacon et al., 1985). Since the electron transport 
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chain is imbedded in the inner mitochondrial membrane, it seems possible that a change in 
membrane properties induced by lipid peroxidation might be responsible for the observed 
defects (Britton et al., 1987). 
Associated anomalies in hepatic microsomal function have been reported including 
drastic reductions in concentration and activity of cytochrome P-450 (Nordman et al., 
1987). It could be that the Fe-initiated lipid peroxidation decomposes the lipid envelope 
in which cytochrome P-450 is embedded, destroying its functional integrity, as has been 
theorized for other lipid peroxidation initiators (Recknagel and Glende, 1973). There is 
also evidence of largely decreased rotational mobility of the P-450 protein, in Fe-catalyzed 
peroxidized rat liver microsomes. This motion of the protein seems to be needed to allow 
the electrons transfer in the system (Richter, 1987). Iron overload in experimental animals 
can result in lipid peroxidation in vivo, as evidenced by increased alkane exhalation, 
TBARS production and lipid conjugated dienes. Iron overload produced induced 
parenterally with iron dextran increases lipid peroxidation in rats, measured as exhaled 
ethane and pentane (Dillard and Tappe!, 1979). Several studies report elevated levels of 
TBARS in liver and other tissues of rats given injections of iron d~xtran (Britton et al. , 
1987). Britton's group has reported increased levels of TBARS in the livers of rats fed 
dietary carbonyl iron (Britton et al., 1987). The presence of elevated levels of conjugated 
dienes in hepatic microsomes, and increased amounts of urinary thiobarbituric acid 
reactants in rats fed dietary carbonyl iron has been confirmed (Meydany et al., 1987). 
Studies in patients 
The key question of whether lipid peroxidation occurs in vivo in patients with Fe 
overload has not yet been resolved. However, several studies point in that direction. It 
has been reported that erythrocytes from Fe-loaded thalassemic patients show an 
increased susceptibility to in vitro lipid peroxidation when exposed to a peroxide 
challenge (Britton et al., 1987). Homogenates of Fe-loaded spleens from patients with 
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thalassemia produced greater amounts of TBARS and fluorescent products than those 
from patients without Fe overload, when incubated in vitro (Britton et al., 1987). 
Elevated levels of activity of several lysosomal enzymes, have been observed in 
liver biopsies of patients with Fe overload (Britton et al., 1987). Lysosomes isolated from 
liver biopsy specimens from patients with Fe overload have increased membrane fragility 
in vitro (Peters et al., 1985); this increase in fragility returns to normal in patients with 
hemochromatosis after chronic phlebotomy therapy. 
People suffering different degrees of Fe overload might be affected not only by 
direct lipid peroxidation compromising the cells survival, but also by indirect lipid 
peroxidation effects on metabolic pathways. The metabolism of xenobiotics by the 
cytochrome P-450 system of enzymes in hepatic tissues could be one of them. Not much 
is known about the level of Fe overload at which such indirect effect could take place in 
humans, but relatively subtle changes in membrane constitution could affect the active site 
of membrane bound enzymes (Richter, 1987). 
Effect in glutathione peroxidase activity 
Soluble enzymes can also be affected by Fe overload. There is evidence of 
decreased Se-dependent GSHPx activity in animals under Fe overload (Lee et al., 1981; 
Reffet et al., 1986). Reffet et al. (1986) induced dietarily Fe overload in lambs and 
observed decreased activity of Se-dependent glutathione peroxidase (GSHPx) in liver but ...______ 
not in lung or spleen. Lipid peroxidation, based on measurement of malonaldehyde 
formation in homogenates of liver, spleen or lung, was not affected by the dietary Fe. 
Lee et al. (1981), using male Sprague Dawley rats, evaluated GSHPx activity during 
intake of excess dietary Fe and Se deficiency; a decrease in liver Se-dependent GSHPx 
activity was observed. Liver Se-dependent GSHPx decreased markedly during Se 
deficiency. Lipid peroxidation, estimated by the thiobarbituric acid method, was elevated 
in the Fe overloaded animals compared with controls. No explanation for the observed 
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effect of Fe overload on Se-dependent GSHPx is available. 
IRON DEFICIENCY 
In considering the effect of Fe deficiency on the activities of various enzymes it is 
apparent that depletion of enzymes and their repletion is largely tissue specific. Iron 
deprivation might affect most severely those tissues which have a rapid growth and rate of 
cell division. 
Pascoe et al. ( 1983) have demonstrated that dietary deprivation of Fe can decrease 
the intestinal cytochrome P-450 content and activity. ~y contrast, liver cytochrome P~450 
has been shown to be highly resistant to Fe deficiency (Dallman and Goodman, 1971). 
Relatively little is known of the effect of Fe deficiency on the functions of peroxidases. 
Lowered levels of GSHPx have been described in Fe-deficient rabbits (Rodvien et al., 
1974) and man (MacDougall, 1972). The basis for such a decrease is not clear since 
GSHPx is a Se containing enzyme. 
Rat pups are popular experimental models for the study of the role of dietary Fe in 
lipid metabolism. Hypertriglyceridemia and fatty livers have been observed in pups of Fe-
deficient rats, and Fe supplementation reverses the lipid accumulation. A feasible 
explanation relies in the requirement of Fe for the synthesis of carnitine, an essential 
cofactor for oxidation of normal fatty acids (Bartholmey and Sherman, 1985). 
Iron has also an integral role in the production of unsaturated fatty acids; in rats 
fed a Fe-deficient diet, the ratio of mononunsaturated to saturated fatty acids in tissue 
lipids is reduced. This seems to be a consequence of a reduction in the activity of an Fe-
containing desaturase enzyme complex found in several tissues (Larkin et al., 1986). 
Also in pups, it has been observed that Fe deficiency can alter the fatty acid composition 




The enzyme glutathione peroxidase (GSHPx) was discovered in erythrocytes 
(Mills, 1957). It was then described as capable of protecting hemoglobin from oxidative 
breakdown by catalyzing the reduction of hydrogen peroxide to water (Mills, 1957). A 
decade later, the enzyme was also found to catalyze the reduction of organic 
hydroperoxides formed from unsaturated fatty acids (Little and O'Brien, 1968). With this 
new finding, a far broader role for the enzyme in detoxication and in the protection of cell 
membrane against peroxidative damage was established. GSHPx is considered an 
important cell line of defense against lipid peroxidation (Wendel, 1980). 
In the early 1970s, Se was discovered as an integral part of GSHPx (Rotruck et 
al., 1973; Flohe et al., 1973); the essentiality of this element was then established. 
Subsequent studies have shown that the activity of GSHPx in animal tissues is directly 
related to the availability of dietary Se (Smith et al., 1974; Hafeman et al. , 1974; Knight 
and Sunde, 1987). In rats fed a diet with less than 0.02 ppm Se, liver GSHPx activity 
decreased to undetectable levels by day 21 (Knight and Sunde, 1987). Feeding rats for 
28 days with a Se-deficient diet, Reddy and Tappel (1974) found a significantly lower 
GSHPx activity in the unsupplemented rats. Nalini et al. (1976), using a 0.014 ppm Se 
diet, found a slight decrease in the intestinal mucosa after 24 days of treatment. They 
concluded that the slow decline in enzyme activity may be explained by the accessibility of 
residual dietary Se to the mucosal cell. Pascoe et al. (1983) found significantly lower 
GSHPx activity in the intestinal cells of rats after 3 days of a Se-deficient diet (0.01 ppm 
Se). 
In 1976, it was discovered that Se-deficient rat liver had GSHPx activity that was 
independent of Se (Lawrence and Burk, 1976). This activity is catalyzed by one or more 
of the GSH-S-transferases (Prohaska and Ganther, 1977). The activity of this Se-
independent GSHPx is not decreased in a Se-deficient diet. The Se containing enzyme 
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utilizes hydrogen peroxide and organic hydroperoxides as substrates, whereas the Se-
independent GSHPx has a far greater specificity for organic hydroperoxides. It has been 
emphasized that there is potential error associated with assessment of the Se status of an 
animal by measuring GSHPx with organic hydroperoxides in tissues having Se-
dependent and Se-independent enzymes (Scholz and Hutchinson, 1979). The use of 
organic hydroperoxides such as cumene-hydroperoxide or t-butyl hydroperoxide for the 
determination of Se-dependent GSHPx is not recommended unless the absence of GSH-S-
transferases has been confirmed chromatographically. This is the case in intestine where 
the absence of Se-independent GSHPx was confmned (Lawrence and Burk, 1976). 
Influence on xenobiotics metabolism 
There is evidence that in severe Se deficiency there may be decreases in some 
forms of hepatic cytochrome P-450, especially when inducers of the enzyme such as 
phenobarbital are administered to the rats. Se seems to be required for the maintenance of 
one or more forms of cytochrome P-450 (Burk and Correia, 1981). However, Reiter and 
Wendel (1983, 1984) did not observe any significant change in the cytochrome P-450 
activity assayed with aniline (hydroxylation) or with aminopyrine (demethylation) after 2 
and 6 months of feeding a Se-deficient diet. They detected, instead, a 330% increase in 
the cytochrome P-450 activity when assayed with 7-ethoxycoumarin (deethylation); and a 
240% increase in heme oxygenase activity, an enzyme involved in heme catabolism. 
These authors observed that a dietary Se content of 0.01 ppm was required for the 
induction of these enzymes; with a diet of 0.05 ppm Se, they failed to induce any 
significant changes. These reports indicate that the overall influence of Se on xenobiotic 
metabolism by cytrochrome P-450 is likely to be very complex. 
Se deficiency causes and increase in hepatic glutathione S-transferase activity 
(Lawrence et al., 1978). It also increases the synthesis of glutathione (Hill and Burk, 
1982). These should increase the ability of the liver to detoxify substances via the 
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glutathione conjugation pathway (Lin et al., 1984). 
Cancer 
Epidemiological evidence shows an inverse relationship between dietary Se intake 
and certain forms of cancer in humans, especially colon, rectum, and breast cancer. 
Some studies also show an inverse association between cancer incidence and Se 
concentration in local forage plants and in human blood. An increased incidence of those 
cancers in geographic areas where Se is deficient has been demonstrated in the United 
States and globally (Jacobs, 1977; Schrauzer, 1976). 
The association between levels of Se in serum and subsequent risk of 
gastrointestinal cancer was investigated in Finland, an area of the world very low in Se. 
Men and women initially free of cancer were studied, and it was found that subjects with 
a low level of Se had an elevated risk of cancer of the upper gastrointestinal tract (Knekt et 
al., 1988). 
It is possible that Se deficiency does not cause cancer but increases the 
susceptibility to cancer induction (Whanger, 1983). Several laboratory investigations 
have shown that Se prevents or retards the genesis of a number of chemically and virally 
induced or transplanted tumors (Griffin, 1979). In general, Se will counteract, to varying 
degrees, the effects of chemical carcinogens used to produce lesions of the skin (eg., 
coaltar); liver (eg., aflatoxin B 1), mammary gland (eg., nitrosoureas); and intestinal tract 
(eg., nitrosamine, dimethyhydrazine, and azoxymethane) (Whanger, 1983). 
Mechanisms of action 
Se may influence carcinogenicity by interfering with the activity of enzymes 
involved in metabolic activation of precarcinogens as well as by enhancing the 
detoxication pathway (Lin et al., 1984). As a constituent of GSHPx, Se can affect the 
GSHPx concentration and activity in the cell and, thereby, affect the cellular GSHPx 
defense against the deleterious effects of hydroperoxides (free-radicals). However, no 
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direct relationship between lowered Se-dependent GSHPx protection against lipid 
peroxidation and cancer initiation or promotion has been established. 
Other effects in man 
The most severe Se deficiencies in free-living humans have been reported in 
China. In other parts of the world, researchers observed similarly low Se status in 
patients treated with either therapeutic diets low in Se or with parenteral alimentation. 
Keshan disease is the first human disease shown to be related to Se deficiency. It is a 
cardiomyopathy of children and young women in China that occurs in regions where Se 
levels are extremely low; and prophylactic Se supplementation can eradicate the disease 
(Chen et al., 1980). 
Several cases of cardiomiopathy associated with low Se levels have been reported 
in patients nourished parenterally. The biochemical function of Se associated with the 
cardiomiopathy is unknown (Burk, 1983). However, frank Se deficiency does not occur 
in most of the world. Se deficiency has been also associated with atherosclerosis. Se 
deficiency in rats results in reduced aortic prostacyclin production, probably due to 
hydroperoxide-induced inactivation of prostacyclin synthetase. It also increases plasma 
low-density-lipoprotein cholesterol. Such actions are likely to contribute towards the 
atherosclerotic process (Parnham et al., 1987). 
LIPID PEROXIDA TION 
A free-radical is a chemical compound that has an odd number of electrons and is 
therefore generally highly reactive and unstable. Free radicals can be produced in the cells 
and tissues of our bodies by radiation, and reduction-oxidation (redox) reactions 
involving the transfer of an electron. These redox reactions can be catalyzed by transition 
metal ions or by enzymes (Slater et al., 1987). 
Biological systems find, in molecular oxygen, both benefit and detriment. Thus, 
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while being useful to aerobes as an electron sink for energy-yielding reactions and as a 
reagent for numerous metabolic transformations involving oxidation, it simultaneously 
exerts toxicity. All oxidative damage in biological systems arises ultimately from 
molecular oxygen (DiGuiseppi and Fridovich, 1983). There is a growing awareness that 
membrane lipid peroxidation may be the underlying cause of many forms of oxygen 
toxicity. The reactive species which initiates lipid peroxidation in biological systems has 
not been identified. The nature of the oxygen involved in the process is still under 
investigation. The hydroxyl radical HO·, superoxide anion 0·2, singlet oxygen 102, and 
the hydroperoxy radical HOO· have all been considered (Wills, 1985). 
Lipid peroxidation is a free-radical mediated process that can result in acute cell 
injury if the normal protective mechanisms of the cell are overwhelmed. In a cellular 
context, lipid peroxidation often utilizes as substrates the polyunsaturated fatty acids 
(PUFA) in membranes (plasma membrane, endoplasmic reticulum, mitochondrial 
membrane, etc) (Slater et al., 1987). In a process called initiation, PUFA are converted 
via H. abstraction into lipid free-radicals. This process is catalyzed by the presence of 
trace amounts of transition metals such as Fe. R· + PUFA (H)---- RH + PUFA. The 
lipid free-radicals are in turn oxidized by molecular oxygen to lipid peroxy radicals. 
PUFA + 02---- PUFAOO·. PUFAOO· radicals are able to extract H· from new PUFA 
(H) atoms in a process referred to as propagation. Propagation stages involve bond-
rearrangement to give diene conjugates (Slater et al., 1987). 
The important role of Fe in both enzymatic and non-enzymatic lipid peroxidation 
has been confirmed by numerous studies. However, the mechanism by which Fe 
promotes lipid peroxidation has not been elucidated. A generally accepted theory is that 
Fe may serve as a catalyst for the formation of the highly reactive hydroxyl radical (·OH) 
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which initiates lipid peroxidation. As a catalyst, Fe functions as an electron acceptor 
from 02·- as well as a Fenton's Reagent for the generation of ·OH from H202. 
02·- +Fe3+ --- 02 + Fe2+ 
202·- + 2H+ --- 02 + H202 
H202 + Fe2+ --- Fe3+ + OH +·OR-
This sequence of reactions is often called the superoxide-driven Fenton's reaction (Minotti 
and Aust, 1987). 
Other important theories are also being investigated (Minotti and Aust, 1987); 
among these, one proposes that Fe, itself, is the actual initiator of lipid peroxidation. In 
this theory it is proposed the envolvement of oxygen to bridge Fe3+ and Fe2+ in a Fe2+-
dioxygen-Fe3+ complex. It is suggested that different electric charges in Fe complexes 
creates "a sort of nidus" for oxygen, capable to capture electrons from unsaturated lipids 
or other oxidizable substrates. 
Cancer 
There is general agreement that tumor cells are formed conforming to the theory of 
initiation-promotion. Compounds which cause initiation are usually thought to bind DNA 
and to cause irreversible molecular damage. Promoters, on the other hand, are thought to 
bind to cell membranes and be reversible. Promoters are thought to enhance the activity 
of initiators. Some agents act as both initiators and promoters (eg., some chemicals and 
radiation). Many think the two-step mechanism occurs with all carcinogenic agents, but 
chemical carcinogens most clearly follow this example. Both initiators and promoters 
involve free-radicals (Weinstein, 1981 ). 
Chemical alterations and damage to DNA may be produced in the various steps of 
lipid peroxidation. During initiation, as a direct reaction between oxygen radicals and 
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DNA, and during propagation with the reaction between DNA and the lipid radicals. 
Here, DNA acts as a radical scavenger/antioxidant, since it stops the lipid peroxidation 
process at either level of initiation or propagation. A third mechanism could be the 
reaction of DNA with non-radical products of lipid peroxidation (Vaca et al., 1988). 
However, experimental evidence for the involvement of the interaction between 
lipid peroxidation products and DNA in the initiation and promotion steps of 
carcinogenesis has not yet been presented and the proposal for such a causative 
relationship is primarily based on the effects of dietary fats on cancer incidence and on the 
observation that the most important human defense mechanisms against mutagens and 
carcinogens are the same as those that operate against oxygen radicals and lipid 
peroxidation (Slaga et al., 1983). Among them, Se and glutathione peroxidase has been 
found to have antimutagenic and anticarcinogenic activity (Knuutila, 1984 ). The 
supposition that oxygen-free-radicals are involved in carcinogenesis is based on recent 
exciting but controversial evidence from a number of diverse studies. Much research 
emphasis linking free-radicals and cancer has focused on intermediates of oxygen 
reduction such as superoxide anion and hydroxyl radical. Although the peroxyl radical 
has received less attention, it may be just as important biologically as reduced oxygen 
intermediates (Marnett, 1987). 
There is a lack of suitable methods which can be utilized to study free-radical 
reactions and the formation of marker products to free-radical reactions. The progress 
made in determining oxidative damage to DNA has been mostly in vitro. The analysis of 
in vivo models seems a very difficult task. In spite of the growing collaboration between 
free-radical researchers and carcinogenesis investigators, it is generally felt that it will be 
experimentally much more difficult to demonstrate a connection between oxygen radicals 
and carcinogenesis than it has been to make the same connection between certain 
xenobiotics and cancer. 
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Aging and atherosclerosis 
The idea that lipid peroxidation is responsible for aging phenomena has attracted 
many researchers. This hypothesis is supported by the accumulation of lipofuscin 
granules in the cellular matrix during the aging process. However, the granules, even if 
they originate from lipid peroxidation, seem to be quite inert and without any effect on cell 
regulation (Tappe!, 1970). 
Lipid peroxidation may be linked to the etiology of atherosclerosis. Atherogenesis 
is enhanced by substances capable of irritating the arterial wall. A possible constant 
source of irritating compounds is the reaction of molecular oxygen with the 
polyunsaturated compounds present in serum and arterial-wall lipids. Lipid peroxidation 
could directly damage the endothelial cells promoting the process of atherosclerotic lesion 
formation (Henning and Chow, 1988). 
Lipid peroxidation measurement 
As already discussed, lipid peroxidation in biological systems consists of a 
complex series of reactions which include many intermediates and products. A number of 
analytical techniques which measure some of these intermediates and products have been 
applied to detect lipid peroxidation in vivo. Substances derived from peroxidizing lipids 
that have been measured in vivo include ethane and pentane, fluorescent products, 
thiobarbituric acid reactive material, lipid hydroperoxides, lipid hydroxy acids, aldehyde 
products, adducts of aldehydes with lipid and protein, and lipid conjugated dienes 
(Kappus, 1985). To determine whether lipid peroxidation has occurred in vivo, it is 
essential to measure a peroxidation product which was produced in vivo. This involves 
employing analytical procedures which prevent any artifactual peroxidation from taking 
place during sample processing. The thiobarbituric acid test (TBA) involves reacting the 
sample with TBA under acidic conditions and elevated temperatures (80-lOOoC), and 
measuring the absorbance at 535nm. In biological systems, malonaldehyde (a breakdown 
product of lipid peroxidation) appears to be the predominant TBA reactant, although other 
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substances can react with TBA (TBARS) and contribute to the absorbance at 535 nm. 
Britton et al. ( 1987) uses homogenization of liver samples with 5% trichloroacetic 
acid to denature proteins, allowing both proteins and the lipids associated with them to be 
removed by · centrifugation. This leaves a supernatant which is essentially free of 
substrate for any Fe-induced peroxidation, which may occur during the TBA assay itself. 
Alternatively, when tissue samples are directly assayed in the TBA test, the use of 
butylated hydroxytoluene in the assay mixture has been recommended to prevent Fe-
induced lipid peroxidation (Buege and Aust, 1984). 
Because of the growing importance of lipid peroxidation in the biomedical field, 
there is an increasing need for reliable methods to detect these processes in vivo . 
Pompella et al. (1987) compared the methods more commonly used in various 
laboratories to detect lipid peroxidation in vivo: measurement of the malonaldehyde 
content of the liver; detection of diene conjugation absorption in liver phospholipids; 
measurement of the loss of polyunsaturated fatty acids in liver phospholipids; and 
measurement of the carbonyl functions formed in the acyl residues of membrane 
phospholipids. They wanted to determine if the methods correlate and to test the 
reliability of each individual method. Correlations among the values obtained with these 
methods were high significant statistically, indicating that the procedures measure lipid 
peroxidation in vivo with similar reliability. 
THE INTESTINAL TRACf 
Relevance of extrahepatic metabolism 
The interfaces between man and his environment are several, and the 
gastrointestinal tract is a major interface. The small intestine offers, itself, a total epithelial 
surface area of 2,000 ft2 (Hinkle, 1972). Food and drink represent the most complex 
mixture of chemicals to which humans are obligatorily exposed, and many sources of 
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occupational exposure may also end up in the gastrointestinal tract. The gastrointestinal 
mucosa is a site of extra-hepatic drug metabolism. It may also play a role in excretion: by 
producing conjugates of absorbed compounds which are returned to the intestinal lumen 
by excretion or cell sloughing and therefore never reach the circulatory system (V ainio 
and Hietanen, 1980). The rate of extrahepatic xenobiotic metabolism may not be as high 
as in the liver and the total capacity may also be lower, but human exposure to both 
environmental and occupational foreign compounds is often a chronic situation in which 
only small quantities at a time enter the body. Since almost all absorption and digestion of 
food and water occurs in the small intestine, the study of metabolism at the intestinal level 
becomes relevant. 
In the intestinal mucosa, as in the liver, several of the metabolic biotransformation 
reactions are catalyzed by the microsomal mixed function oxidase (MFO) system, of 
which cytochrome P-450 and NADPH cytochrome P-450 reductase are key components. 
However, the cytochrome P-450 content of the intestine is much less than that of the liver; 
0.1 vs 0.9 nmol/mg microsomal protein, respectively (Vainio and Hietanen, 1980). 
Previous studies indicate the existence of a gradient in mucosal MFO activity from the 
duodenum to the colon that closely parallels a similar gradient in intestinal absorptive 
capacity. In addition, the most mature epithelial cells at the mucosal villous tips, pivotal 
in absorption of intraluminal constituents, are also the richest in cytochrome P-450 
content and related MFO activity (Pascoe et al., 1983). 
More than 20 cytochrome P-450 isozymes have been purified, and according to 
some investigators, the total number of existent cytochrome P-450 isozymes could be 
potentially enormous (Lu and West, 1980). These studies have been done in several 
mammalian species and in fish. The isozymes vary with the species, organ, tissue, type 
of cell (in a common tissue), sex, and age of the organism (Lu and West, 1980). These 
isozymes can be induced by a wide spectrum of natural and synthetic substances in the 
environment and diet as well as by products of the normal physiological processes. 
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Induction of the intestinal cytochrome P-450 enzymes due to dietary manipulation has 
been the subject of several investigations (Salbe and Bjeldanes, 1985). Intestinal MFO 
activity is minimal in rats fed a semi-synthetic diet and which have been starved for one to 
three days. It has been suggested that the major part of drug metabolising enzyme activity 
in the gut is due to exogenous inducers in the diet, flavones contained in standard 
laboratory chow for instance, are intestinal cytochrome P-450 inducers (Wattenberg, 
1971). Most cancers develop in epithelial tissue (Cone and Nettesheim, 1973). Thus, 
the events that take place at the gastrointestinal mucosa, and that could eventually affect 
the systems that control the differentiation and proliferation of these epithelial cells, are 
extremely important. 
More recently, the activation of several kinds of substrates, some of them 
intestinal carcinogens, has been associated with cooxidation with prostaglandin H 
synthetase (PHS). PHS activity is relatively high in many extra-hepatic tissues which are 
low in MFO activity. Krauss and Eling (1984) proposed that PHS could be an alternative 
or additional enzyme system for the metabolic activation of compounds which exhibit 
extra-hepatic toxicity and carcinogenicity. 
Intestinal glutathione peroxidase 
The presence of hydroperoxides in the cell controls the balance between the 
lipoxygenase and cycloxygenase pathways (Reddy and Massaro, 1983). Since both, Se-
dependent and Se-independent GSHPx can effectively decompose fatty acid 
hydroperoxides, they may play an important role in the control of the presence of cellular 
hydroperoxides, and in turn, in the modulation of the cyclooxygenase and lipoxygenase 
pathways in vivo. 
All the above described events are happening in an epithelial tissue which has an 
especially fast turnover of only 36 hours (Loehry et al., 1969). It has been suggested that 
rapidly regenerating tissues such as the intestinal mucosa exhibit inordinately high Se 
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turnover characteristics (Pascoe et al., 1983). The intestinal cell apparently derives its Se 
supplement solely from the diet whereas the liver may derive its Se from body stores 
(Pascoe et al., 1983). However, Nailini et al. (1976) observed a slow decline in GSHPx 
activity in the intestinal mucosa after 24 days of a Se-deficient diet. Reddy and Tappel 
(197 4) reported a 50% decrease in GSHPx activity of the intestinal mucosa of of rats after 
28 days of feeding a Se-deficient diet. These are much more slower rates of decrease than 
those reported for liver. 
The relatively fast cell turnover of the intestinal mucosa also makes this epithelia 
particularly susceptible to the action of free-radical.s and radiation. This is probably true 
also for mutagens and carcinogens which can originate from the diet and exert their 
toxicity through the generation of oxygen radicals (Ames, 1983). The epithelia of the 
gastrointestinal tract is then unavoidably exposed to oxygen radicals that are generated in 
the epithelial cells of the mucosa and also within the lumen (Grisham et al., 1987; 
Granger et al., 1986). These radicals could, in turn, lead to the oxidation of fat in cellular 
membranes of the epithelia by a lipid peroxidation chain reaction, especially if the cell's 
regular protection against lipid peroxidation is reduced. 
These dangerous reactive products must be promptly eliminated, and this is 
accomplished in cells by several lines of defense including superoxide dismutase which 
converts 02·- into H202 as well as catalase and peroxidases which convert H202 into 
H20 plus 02 (Robinson and Thomson, 1983). As discussed before, GSHPx has central 
importance in protecting against the pro-oxidative consequences of metabolic activation of 
oxygen (generation of OH) via the reduction of H202 in the cell. It aids in blocking the 
free-radical formation and subsequent attack of membrane phospholipids and critical 
proteins (Mills, 1957, Little and O'Brian, 1968). Since the intestinal mucosa lacks Se-
independent GSHPx (Levander, 1982), its acute dependency on intraluminal sources of 




Compared with liver, much less information about intestinal Fe-overload is 
available. Rats injected with iron sorbitol citrate did not have a significant increase in the 
concentration of Fe in the Fe-loaded intestinal epithelial filtered homogenates (Richmond 
et al., 1972). This could be due to a relatively low total dose of injected Fe (40 mg), and 
to the fact that the rats were killed 10 days after the last Fe injection. 
Gavino et al. (1984 ), working with iron dextran injected rats, found increased 
levels of Fe in intestinal rings (1cm piece of small intestine 5cm distal to the stomach). 
But, they did not find increased lipid peroxidation (measured as total ethane and pentane) 
in those rings. However, the intestinal mucosal tissue makes up a very small fraction of 
these rings which would mask any effects of Fe-overload on this tissue. 
In Fe overloaded rats fed a laboratory chow diet containing 2% carbonyl iron for 6 
months, it was observed that the excess of Fe accumulated in hepatocytes lysosomes after 
Fe-loading which is released from the lysosomes into bile. Biliary Fe is then excreted in 
the intestinal tract. It is assumed that, similar to biliary copper, the excreted Fe is poorly 
absorbed by the intestine after biliary excretion (Le Sage et al., 1986). 
It has been suggested that carbonyl iron can be absorbed from the duodenal 
mucosa without the participation of ferritin and transferrin (Nakamura et al., 1988). 
Also, the role of Fe in producing oxidant-mediated injury to the gastric mucosa in vitro, 
was investigated. It was concluded that Fe, particularly intracellular Fe, plays an 
important role in mediating oxygen radical damage to gastric mucosal cells. OH., 
produced by the Fe catalyzed Haber-Weiss reaction, seems to be a main mediator of 




Bronaotrichloronaethane (CBrCl3) as tetrachloronaethane (CC14), chloroform 
(CHC13), and several other halonaethanes are con1n1on environnaental pollutants. There is 
plenty of evidence that these three hepatotoxins are lipid peroxidation initiators and they 
require naetabolic activation by cytochronae P-450 to exert toxicity. Cytochrome P-450 
cleaves the halogen-carbon bond forming a halomethane radical as a reaction product. 
The free-radicals in turn initiate a peroxidative deconaposition of liver cell structural lipids 
leading to liver necrosis (Recknagel and Glende, 1973). Anaong other sources of 
evidence, the use of inhibitors or inducers of cytochronae P-450 drastically reduces the 
toxicity of CC14. These known hepatoxins are also suspected as carcinogens (Sittig, 
1985). Less is known about the naechanisna by which those halonaethanes naay participate 
in the process of carcinogenesis, but as discussed before, lipid peroxidation, itself, and 
sonae of its by-products are inaportant potential initiators and pronaoters of cancer. 
It has been denaonstrated that CBrCl3 beconaes covalently bound to DNA after 
bioactivation. This is an inaportant piece of information since one of the prevailing 
theories of chenaical carcinogenesis is that the initiating agents interact with DNA (Direnzo 
et al., 1982). Bronaonichloronaethane is a better lipid peroxidation initiator than CCl4 and 
CHCl3 probably due to a relatively lower energy requirenaent for the cleavage of the C-Br 
bond to produce the ·CC13 free-radical (Reck .. nagel and Glende, 1973). It has an oral 
LDso in rats of 200 nag/kg conapared with an LDso of 2800 nag/kg for CCl4 (NIOSH, 
1985). 
Higher in vitro naalonaldehyde production in rat liver naicrosonaes exposed to 
CBrCl3 as conapared with that of liver naicrosomes exposed to CCl4 has been reported 
(Slater and Sawyer, 1971 ). In vitro assays with tissue slices of intestinal tract, CBrCl3 
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initiates lipid peroxidation. It has been suggested that CBrCl3 could act at organs other 
than liver (Gavino et al., 1984; Fraga et al., 1987). However, no in vivo work has been 
done to elucidate this any further. 
Se and Fe influence on bromotricholomethane 
High levels of Se are known to protect against CCl4 toxicity (Benedetti et al., 1979). 
While Se deficiency and the consequent decrease on Se-dependent GSHPx activity 
augments the toxicity of lipid peroxidation initiators such as Fe overload (Dougherty et 
J 
al., 1981), or CCl4 (Hafeman and Hoekstra, 1977), the potential effect of Se deficiency 
in BrCl3C toxicity has not been assayed in vitro or in vivo. On the other hand, induction 
of GSHPx activity due to peroxidative stress caused by ozone exposure, vitamin E 
deficiency and dietary autoxidized lipids has been observed in different tissues including 
the intestinal tract (Reddy and Tappel, 1974). By contrast, GSHPx activity reduction has 
been reported under Fe overload (see Fe overload section) and due to exposure to 2,3,7 ,8-




MATERIALS AND METHODS 
ANIMAL HUSBANDRY 
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Male Sprague-Dawley rats (Simonsen Laboratories, Gilroy, California) were 
housed individually in stainless steel cages with wire mesh bottoms and fronts in a room 
maintained at 25°C and 45% humidity with a 12h light-dark cycle. Food and water were 
available ad libitum. 
Diets 
A torula yeast diet was prepared as presented in Table 1. The Fe and Se contents 
of this diet were 232 ppm and less than .05 ppm, respectively. 
A semi-synthetic diet Fe- and Se-deficient was prepared as described in Table 2. 
A diet with a reduced concentration of com-starch substituted with carbonyl iron was also 
prepared as described in Table 2. 
When supplemented, Fe (75 ppm as FeCl3 -6H20) and/or Selenium (0.5 ppm as 
Na2Se03) were added to the deionized water. Otherwise, deionized water virtually free of 
Se.and Fe (<1 ppb) was available. 
Fe was determined spectrophotometrically using ferrozine for the Fe assay 
(Stookey, 1970) and spectrofluorometrically using 2,3-diaminonaphthalene for the Se 
assay (Koh and Benson, 1983). 
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Table 1--Diet composition, experiment 1 
Ingredienta % 
Torula yeast 30.0 
Sucrose 59.0 
Com Oil 7.0 
Mineral mixture b 3.0 
Vitamin mixturec 1.0 
a Ingredients were purchased at ICN Biochemicals Incorporated, Cleaveland, OH. 
bcAs specified on Nutrient Requirements of Laboratory Animals (The National 
Academy of Sciences, 1978). The mineral mixture (Fe and Se free) contained in glkg diet: 
Dicalcium phosphate, 18.41; Magnesium oxide, 0.67; Potassium citrate, 7.70; Potassium 
sulfate, 1.82; Sodium chloride, 1.27; Chromium potassium sulfate, 0.003; Copper 
carbonate, 0.009; Sodium fluoride, 0.002; Potassium iodide, 0.0002; Manganese 
carbonate, 0.11; Zinc oxide, 0.015. The vitamin mixture contained in mglkg diet: Vitamin 
A acetate, 100.00; Calciferol (850,000 U/gm), 11.80; Alpha tocopherol (250 I.U./gm), 
120.00; Menadione, 0.50; Choline chloride, 10.000.00; Folic acid, 10.00; Niacin, 
200.00; Calcium pantothenate, 80; Riboflavin, 30.00; Thiamine, 40.00; Pyridoxine 
hydrochloride 60.00; Vitamin B-12, 50.00. 
Table 2--Diet composition, experiments 2, 3 and 4 
Ingredienta Regular Iron overloaded 
Com-starch 56.0 54.0 
Dextrose 17.5 17.5 
Casein 12.0 12.0 
Corn oil 10.0 10.0 
Mineral mixtureb 3.0 3.0 
Carbonyl ironC 0.0 2.0 
Vitamin mixtured 1.0 1.0 
Methionine 0.5 0.5 
anextrose, oil and corn-starch were purchased at local stores. All other ingredients 
were purchased from ICN Biochemicals, Inc., Cleveland, OH. 
bdThe compositions of the vitamin and mineral mixtures are shown in Table 1. 




Rats (210-230g) were fed the torula yeast diet for 20 days. The Fe and Se 
contents of the diet were 232 ppm and less than 0.05 ppm respectively. Fe overload was 
induced in some of the animals by intramuscular injections of iron dextran (100 mg Fe/ml; 
Sigma Chemical Co.) up to a total of 75 mg Fe per 100 g body weight, following the 
system used by Dillard et al. (1984 ). The dose was divided in three equal injections 
delivered on days 4, 9, and 14 of the experiment. The remaining rats were sham-injected 
with physiological saline. Animals were randomized into 4 groups of 15 animals each: Se 
and Fe supplemented animals (+Se+Fe), were supplied Se in the water as described 
above; Se-deficient and Fe supplemented animals (-Se+Fe), were supplied deionized 
water. Se supplemented and Fe overloaded animals (+Se++Fe), were supplied Se in the 
water and injected with iron dextran; and Se-deficient and Fe overloaded animals 
(-Se++Fe) were supplied deionized water and injected with iron dextran. The animals 
were fed their respective diets for 20 days. On days 15-19 of the experiment, five animals 
from each of these groups were treated with CBrCl3 (9.9 mM/ml) diluted in 0.5 ml of 
mineral oil (dose I: 0.05 j..!l/kg b.w./day) and five more with CBrCl3 (dose II: 0.5 j..!l/kg 
b.w./day) . The five remaining animals from each group were designated as controls and 
gavaged with mineral oil only. All the animals were killed on day 20, 24 hr after their last 
CBrCl3 dose. 
Experiment two 
For two months, rats (70-90 g) were fed the semi-synthetic Fe and Se-deficient 
diet or the Fe overloaded diet (as described by Bacon et al., 1986) and Se-deficient diet. 
The Fe and Se content of this diet was 12 ppm, and less than 0.05 ppm respectively. 
Animals were randomized into 4 dietary groups of 10 animals each: Se and Fe 
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supplemented animals ( +Se+Fe) were given Se and Fe in the water; Se-deficient and Fe 
supplemented animals (-Se+Fe) were given only Fe in the water; Se supplemented and Fe 
overloaded animals ( +Se++Fe), were fed the carbonyl iron diet and supplemented with Fe 
and Se in the water; Se-deficient and Fe overloaded animals (-Se++Fe), were fed the 
carbonyl iron diet and supplemented with only Fe in the water. Bromotrichloromethane 
(9.9 mM/ml) diluted in approximately 0.5 ml of mineral oil was given by gavage, at a 
dose of 5.0 jll/k:g b.w./day, for five consecutive days, to 5 animals in each of the different 
dietary groups. The remaining five animals in each dietary group, were sham-gavaged 
with mineral oil and designated as control groups. Twenty four hours after the last 
gavage the animals were sacrificed. 
Experiment three 
Rats (250-275g), were fed the semi-synthetic Fe- and Se-deficient diet (Table 2). 
The Fe and Se contents of this diet were 10 ppm and less than 0.02 ppm. The availability 
of a source of casein exceptionally low in Se content (from ICN Biochemicals, Inc., 
Cleveland, OH) allowed us to prepare a diet with a particularly low Se content. Animals 
were randomized into 4 groups of 5 animals each: Se and Fe supplemented animals 
(+Se+Fe) given Se and Fe in the water; Se supplemented and Fe-deficient (+Se-Fe) 
animals were given only Se in the water; Se-deficient and Fe supplemented (-Se+Fe) 
animals given only Fe in the water. Selenium- and Fe-deficient animals (-Fe-Se) given 
the deionized water free of both elements. All the animals were fed the above diet for 20 
days prior to sacrifice. 
Experiment four 
For three months, rats (70-90g) were fed a semi-synthetic Fe- and Se-deficient 
diet with an Fe and Se content of 15 ppm and less than 0.05 ppm, respectively, or a 
carbonyl iron diet (Table 2). Animals were randomized into six dietary groups of ten 
animals each: Se and Fe supplemented animals (+Se+Fe) given Se and Fe in water. 
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Selenium supplemented and Fe-deficient animals (+Se-Fe) given Se only in the water. Se-
deficient and Fe supplemented animals (-Se+Fe) given only Fe in the water. Iron- and Se-
deficient animals (-Se-Fe) given deionized water only. Iron overloaded and Se 
supplemented animals (+Se++Fe) were fed the carbonyl iron diet and given Fe and Se in 
water as described above. Iron overloaded and Se-deficient animals (-Se++Fe) were fed 
the carbonyl iron diet and given Fe only in the water. Four hours before sacrifice 5.00 J..Ll 
CBrCl3 (9.9 mM/ml/kg b.w., dissolved in 0.5 ml mineral oil) were given by gavage to 
five animals from each of the four dietary groups (+Se+Fe, +Se-Fe, -Se+Fe, -Se-Fe). 
The remaining five animals in each group were designated as control groups. 
SAMPLE PREPARATION AND ANALYSES 
Homogenates preparation 
Rats were decapitated and exsanguined and the livers dissected and placed in 
isotonic KCl. The intestinal tract was excised from the stomach at the pyloric junction and 
gently pulled away from the mesentery. A 30 em section of small intestine was taken 
beginning at the pyloric junction and placed in isotonic KCl. A 2 em section was also 
taken starting at the point where the first section ended. Both sections were flushed with 
30 and 10 ml of isotonic KCl, respectively, to wash out the intestinal contents. The 30 em 
section was split longitudinally along the mesenteric axis. Excess liquid was removed 
with ashless paper tissue and the epithelial mucosa gently scraped with the edge of a metal 
spatula. The mucosal scrapes were weighed and homogenized in 3 volumes of KCl tris 
buffer (150/25 mM) pH 7.5, with five strokes at full speed of a bio-homogenizer 
(Bioespec Products, Inc., model M 133/1281-0). A very similar procedure has been 
previously reported (Pascoe et al., 1983; Craven and DeRubertis, 1980). The intact 2 em 
intestinal sections were similarly homogenized. The livers were blotted dry on filter paper 
and weighed. Liver homogenates were prepared in 2 volumes of KCl tris buffer (150/25 
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mM) pH 7.5 with a Polytron tissue homogenizer (Brinkmann Industries, model PT 
45/80) with five strokes at intermediate (5) intensity speed. All the procedures were 
conducted in a cold-room at 4 °C. A 1 ml homogenate aliquot of each tissue was wet 
-ashed, described below, and a 0.3 ml homogenate aliquot was frozen in liquid nitrogen 
and stored at -70°C for future protein content determination. Following the same 
procedure, a 5 mlliver homogenate aliquot was stored for cytochrome P-450 assay. The 
remaining homogenates were centrifuged at 10,000 G and 4 °C for 10 minutes in an 
International Equipment Company centrifuge, model HR-1. The 10,000 G supernatants 
(lOS), were placed in 2 ml store vials, frozen in liquid nitrogen and stored at -70°C for 
further assays. 
Analytical procedures 
Iron was determined in 1 ml of whole homogenates of liver, gastrointestinal 
mucosa and intestinal rings after wet-ashing with HN03 and H202 to dryness and then 
diluted to the appropriate volume with hydrochloric acid. Serum diluted with deionized 
water was also analyzed for Fe. Iron was quantified spectrophotometrically, using 
ferrozine color reagent (Stookey, 1970; see Appendix A for details). Samples were 
assayed in triplicate. Precision for the triplicates was .43 ±.77 (mean ±standard 
deviation) j.lg Fe/ml homogenate. 
Se-dependent GSHPx activity was measured in the diluted liver and intestinal 
supernatants, using H202 substrate. GSHPx activity in human blood was also measured 
and its value compared with the stablished standard, to validate the assay (Paglia and 
Valentine, 1967; see Appendix B for details). Samples were assayed in duplicate. 
Precision for the duplicates was .004 ±.015 (mean ±standard deviation) j.!M 
NADP/min/ml cytosol. 
Lipid peroxidation in liver and intestinal supernatants was measured as 
thiobarbituric acid reactive substances (TBARS). Butylated hydroxytoluene was included 
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in the assay mixture to prevent in vitro lipid peroxidation (Buege and Aust, 1984; see 
Appendix C for details) . A set of assays of a same sample, were repeated over time to 
evaluate possible TBARS generation during sample storage. No increased supernatent 
TBARS level occurred during storage. See Appendix C. Samples were assayed in . 
triplicate. Precision for the triplicates was .88 ±6.82 (mean ±standard deviation) nM 
TBARS/ml cytosol. Cytochrome P-450 activity was assayed in liver homogenates, using 
0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate (EPN) and para-nitroanisol as 
substrates (Kinoshita et al., 1966; see Appendix D for details). Samples were assayed in 
triplicate. Precision for the triplicates was 4.78 ±5.26 (mean ±standard deviation) ~g para-
nitrophenol/h/ml homogenate. 
Protein content of all the homogenate and supernatant samples was determined by 
the binding of Coomassie Brilliant Blue G-250 to protein. Bovine serum albumin was 
used as a reference material (Bradford, 1976; see Appendix F for details) . Samples were 
assayed in triplicate. Precision for the triplicates was .15 ±.42 (mean ±standard 
deviation) ml cytosol. A blood sample was taken from the rat's orbital venous capillary 
bed just before decapitation. Hemoglobin in blood was determined spectrophotometricaly 
as cyanomethemoglobin (Crosby et al. , 1954; see Appendix E for details) . 
Statistical analysis 
Data were analyzed statistically by two-factor analysis of variance and randomized 
complete block design. Orthogonal contrasts were used as tests of significance (Dowdy 
and Wearden, 1983). 
In experiment three data were analyzed statistically by two-way analysis of 
variance and by analysis of variance for a randomized complete block design. When 
applicable, statistical significance was determined by Fisher's least significant difference 
test (LSD) (Dowdy and Wearden, 1983). 
Iron and selenium rats status 
CHAPTER IV 
RESULTS AND DISCUSSION 
EXPERIMENT ONE 
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As shown in Table 3 and Appendix G, Table 18, the animals' weights were 
significantly lower in all groups injected with iron dextran, while Se deficiency or Se-
supplementation did not alter the rats' weights in any of the treatment groups. 
Bromotrichloromethane did not affect the animal weights at either of the two doses. Thus, 
the dose of iron dextran injected was probably toxic for the animals, and the trace amount 
of Se present in the Se-deficient diet was sufficient to prevent the development of critical 
Se deficiency in the rats. It is also probable that the Se body stores of these rats were 
adequate to prevent Se deficiency during the short time of the experimentation. The dose 
of Se supplemented in the water was not toxic to the animals. The lack of effect of the 
CBrCl3 indicates that no obvious systemic toxic effect was induced by the halomethane. 
Hemoglobin values were not significantly different among treatments (Table 3 and 
Appendix G, Table 18) which is consistent with the regulation of red blood cell 
production by the tissue oxygenation needs rather than by the excess of Fe (Harris and 
Kellermeyer, 1974). Serum Fe values were significantly higher in all the groups injected 
with iron dextran (Table 3 and Appendix G, Table 18). High serum Fe values are 
generally associated with increased release of Fe from body stores, a condition seen in 
hemochromatosis (Harris and Kellermeyer, 1974). As shown in Table 4 and Appendix 
G, Table 19, total Fe was significantly higher in the livers (24x), the intestinal mucosa 
(2x), and the whole intestines (7x) of animals injected with iron dextran as compared with 
the control groups. Decreased levels of Fe-binding protein are consistently associated with 
Fe overload, but there is evidence that Fe not bound to its specific transporter is deposited 
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Table 3--Weight, hemoglobin, and serum iron in rats fed a torula yeast diet deficient in 
selenium and injected with iron dextran. 
Measures 
Body weight, g 
f1 (13.55) 
f2 ( 0.87) 
f3 ( 0.58) 
Hemoglobin, g/dl 
f1 ( 0.33) 
f2 ( 0.66) 
f3 ( 0.70) 
Serum Fe, J.lg/ml 
f1 (50.40) 
f2 ( 0.61) 



















































acBrC13 (9.9 mM/ml). Dose I: 0.05J.ll/kg/day. Dose II: 0.5 J.ll/kg/day. Data are means 
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values 
(Alpha = 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) = 
2.3. If any calculated f is higher than the respective table f value, there is a significant 
difference between the compared factors. Orthorgonal comparisons as tests of main 
effects: Values in the same row with the same superscript letter are not significantly 
different. See Appendix G, Table 18. 
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Table 4- Total iron (IJ.g Fe/mg protein) in intestinal mucosa, whole intestine, and livers of 
rats fed a torula yeast diet deficient in selenium and injected with iron dextran 
Tissues 
Intestinal mucosa 






























































acBrC13 (9.9 mM/ml). Dose I: 0.051J.l/kg/day. Dose II: 0.5 IJ.l/kg/day. Data are means 
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values 
(Alpha= 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) = 
2.3. If any calculated f is higher than the respective table f value, there is a significant 
difference between the compared factors. Orthorgonal comparisons as tests of main 
effects: Values in the same row with the same superscript letter are not significantly 
different. See Appendix G, Table 19. 
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in practically all body areas, especially in spleen and liver. It has also been documented 
that in the absence of Fe-binding protein, a greater than normal absorption of Fe from the 
intestinal tract takes place. Studies in man indicate that in the presence of increased 
saturations of Fe-binding protein, Fe continues to be transported across the intestinal 
epithelial cell and delivered to the plasma (Harris and Kellermeyer, 1974). Se-dependent 
GSHPx activity, an indirect parameter of Se status (Smith et al., 1974; Hafeman et al., 
1974), was significantly depressed in the livers (Table 5 and Appendix G, Table 20) and 
intestinal mucosa (Table 6 and Appendix G, Table 21) of the groups fed theSe-deficient 
diet as compared with controls. This indicates a response to the Se-deficient diet fed 
during the 20 days of treatment. Since Se is an integral part of this peroxidase (Rotruck et 
al., 1973; Flohe et al., 1973), this result is in agreement with the reported dependence of 
the enzyme on Se for its activity (Smith et al., 1974; Hafeman et al., 1974). 
Decreased Se-dependent GSHPx activity in the livers of lambs and rats with orally 
induced Fe overload has been reported (Reffet et al., 1986; Lee et al., 1981). However, 
the injected iron dextran did not induce any significant change in hepatic or intestinal Se-
dependent GSHPx activity in this study. A more chronic administration of Fe may be a 
requirement for the modification of GSHPx activity. Reffet et al. (1986) and Lee et al. 
(1981) induced dietary Fe overload over periods of 2.5 and 3.0 months respectively. 
Induction of Se-dependent GSHPx activity in rats due to peroxidative stress 
caused by ozone exposure (Chow and Tappe!, 1972), deficiency of vitamin E (Chow et 
al., 1973), and dietary autoxidized lipids (Reddy and Tappel, 1974) has been reported. 
By contrast, decreased GSHPx activity has been observed in the livers of rats treated with 
2,3,7 ,8-tetrachlorodibenzo-p-dioxin (TCDD), a chemical that induces lipid peroxidation 
(Hassan et al., 1985). The present results indicate that CBrCI3 does not induce a 
significant change in the peroxidase activity. Thus, the observed change in Se-dependent 
GSHPx activity was due solely to the Se-deficient diet. 
Table 5--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS 
production in the livers of rats fed a torula yeast diet deficient in selenium and injected 
with iron dextran 
Dietary treatments 
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Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe CBrCl3a 
GSHPx, ~M NADP/min/mg protein 
f 1 (116) 
f2 (0.9) 




0.18 ±0.06b 0.54 ±0.07a 
0.18 ±0.06 0.62 ±0.08 
0.22 ±0.09 0.55 ±0.07 








1.43 ±0.13abc 1.21 ±0.12b 
1.35 ±0.19 1.52 ±0.37 
1.49 ±0.18 1.35 ±0.20 
P-450, ~g para-nitrophenol/hr/mg protein 
Substrate: EPNb 
f1 (1.5) 1.70 ±0.09a 1.61 ±0.12a 1.45 ±0.25a 
f2 (0.6) 1.55 ±0.06 1.61 ±0.13 1.50 ±0.44 
f3 (0.6) 1.59 ±0.27 1.68 ±0.43 1.54 ±0.33 
TBARS, nM/100 mg protein 
f1 ( 32) 24±3a 20±7a 64 ±16b 
f2 (0.4) 20±7 20 ±1 81 ±36 
f3 (1.1) 21 ±5 20±4 64±10 
0.20 ±0.06b Control 
0.18 ±0.04 Dose I 
0.18 ±0.06 Dose II 
1.40 ±0.20c Control 
1.27 ±0.23 Dose I 
1.34 ±0.12 Dose II 
1.46 ±0.22a Control 
1.33 ±0.12 Dose I 
1.61 ±0.24 Dose II 
72 ±23b Control 
74±32 Dose I 
102 ±49 Dose II 
aCBrC13 (9.9 mM/ml). Dose I: 0.05~1/k:g/day. Dose II: 0.5 ~1/k:g/day. Data are means 
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values 
(Alpha = 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) = 
2.3. If any calculated f is higher than the respective table f value, there is a significant 
difference between the compared factors. Onhorgonal comparisons as tests of main 
effects: Values in the same row with the same superscript letter are not significantly 
different. See Appendix G, Table 20. 
bEPN: 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate. 
38 
Table 6--Glutathione peroxidase (GSHPx) activity and TBARS production in the intestinal 
mucosa of rats fed a torula yeast diet deficient in selenium and injected with iron dextran 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe CBrCl3a 
GSHPx, J.lM NADP/min/mg protein 
f1 ( 31) 0.06 ±O.Ola 0.05 ±0.01b 0.07 ±0.01ac 0.04 ±0.0 1 b Control 
f2 (0.1) 0.07 ±0.02 0.04 ±0.01 0.07 ±0.01 0.04 ±0.01 Dose I 
f3 (0.9) 0.07 ±0.01 0.04 ±0.01 0.07 ±0.01 0.05 ±0.01 Dose II 
TBARS, nM/100 mg protein 
f1 (13.3) 78 ±23a 81 ±27a 102 ±30b 115 ±26b Control 
f2 ( 5.7) 62±16 86 ±12 118 ±32 100 ±26 Dose I 
f3 ( 2.2) 73 ±24 85 ±23 151 ±48 178 ±54 Dose II* 
aCBrC13 (9.9 mM/ml). Dose I: 0.05J.ll/kg/day. Dose II: 0.5 J.ll/kg/day. Data are means 
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values 
(Alpha= 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) = 
2.3. If any calculated f is higher than the respective table f value, there is a significant 
difference between the compared factors. Orthorgonal comparisons as tests of main 
effects: Values in the same row with the same superscript letter are not significantly 
different. The asterisk (*) means that dose II was significantly different from control and 
dose I. See Appendix G, Table 20. 
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A combined condition of lowered GSHPx activity and Fe overload in hepatic and 
intestinal tissues was induced in the animals fed the Se-deficienrdiet and injected with iron 
dextran (Tables 5 and 6 and Appendix G, Tables 20 and 21). 
Cytochrome P-450 activity 
As shown in Table 5 and Appendix G, Table 20, cytochrome P-450 activity in 
liver homogenates was not significantly affected among treatment groups when EPN was 
used as a substrate. The activity of the enzyme assayed with the substrate para-nitroanisol 
was significantly lowered in the animals injected with iron dextran. However, this effect 
was marginal (p < 0.037). Higher doses of injected Fe may be required to inhibit the 
activity of cytochrome P-450 (Bacon et al., 1986). Cytochrome P-450 is required for the 
activation of CBrCl3 by the liver (Recknagel and Glende, 1973). It can be assumed that 
the present experimental conditions did not interfere with the activation of the halomethane 
by the cytochrome P-450 enzyme system. 
Lipid peroxidation 
Lipid peroxidation measured as TBARS production was significantly higher in the 
livers (Table 5 and Appendix G, Table 20) and the intestinal mucosa (Table 6 and 
Appendix G, Table 21) of all the iron dextran injected animals as compared with controls. 
This is in accordance with reports of in vivo enhanced lipid peroxidation in the liver. In 
those reports, acute Fe overload was induced with intraperitoneal injected iron dextran at a 
dose of 125 mg Fe/kg or 500 mg Fe/kg and measured as TBARS and ethane production, 
respectively (Britton et al., 1987). Similar information for the intestinal mucosa is not 
available. The Se-deficient animals did not show any significant differences in hepatic or 
intestinal mucosa TBARS production as compared with controls. Thus, the lowered 
hepatic and intestinal Se-dependent GSHPx activities observed in those animals did not 
induce a higher susceptibility to lipid peroxidation in either tissue evaluated. It might be 
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that under Se deficiency the hepatic Se-independent GSHPx was induced (Lawrence and 
Burk, 1976) protecting the liver against lipid peroxidation. However, since there is noSe-
independent GSHPx activity in the intestinal mucosa (Levander, 1982), this is not a 
feasible explanation for the observed lack of increased intestinal lipid peroxidation in the 
Se-deficient rats. Some of the reported rates of decrease of Se-dependent GSHPx activity 
due to dietary Se deficiency (Nalini et al., 1976; Reddy and Tappel, 1974) are much more 
lower than those reported for the liver enzyme (Hill and Burk, 1982) under similar 
conditions. A diet with a lower Se content fed for a longer period of time might be 
required in order to observe higher lipid peroxidation in both tissues. 
The exposure to CBrCl3 did not significantly affect hepatic lipid peroxidation in 
any of the treatment groups. However, a significantly higher lipid peroxidative activity 
was observed in the intestinal mucosa of the groups exposed to the higher dose of CBrCl3 
as compared with controls. A further analysis of the data (randomized block design, 
Table 7) for the effect of CBrCl3 in each diet showed a significantly higher lipid 
peroxidation in theSe-deficient and Fe overloaded group (-Se++Fe) of animals. This is 
the group potentially most susceptible to lipid peroxidation due to the excess of Fe 
available for the catalysis of lipid peroxidation and also due to the lower activity of 
GSHPx for defense against it. It is known that Se deficiency and the consequent decrease 
on Se-dependent GSHPx activity augmentates the hepatic toxicity of lipid peroxidation 
initiated by Fe overload (Dougherty et al. , 1981 ); but no similar information has been 
reported for the intestinal mucosa. However, the intestinal mucosa is a tissue of high 
potential susceptibility to dietary Se deficiency, due to its dependence on intraluminal 
sources of the metal (Pascoe et al., 1983) and its lack of Se-independent GSHPx 
(Levander, 1982). The results are also in agreement with the previous finding that 
CBrCl3 can stimulate lipid peroxidation in gastrointestinal tissue slices (Fraga et al., 
1987). To explain any further the observed higher susceptibility of the intestinal mucosa 
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Table ?--Intestinal TBARS production data (Table 6) analyzed by randomized complete 

















Table fvalue (Alpha= 0.05); Dose f (2,12) = 3.9. If any calculated fis higher than the 
table f value, there is a significant difference between the compared factors. 
42 
to lipid peroxidation associated with the intake of CBrCl3 as compared with that of the 
liver, we have to speculate. It could be that the liver Se-independent GSHPx enzyme 
activity was induced offering protection against lipid peroxidation. It could also be that 
CBrCl3 reached the intestinal mucosa in a more concentrated dose than that carried by the 
portal circulation from the intestine to the liver, favoring a higher response in the intestinal 
mucosa. In this case, we are also assuming that the activation of CBrCl3 took place in the 
intestinal tract where the free radicals formed were immediately available for the induction 
of lipid peroxidation in spite of their extremely short life. However, we do not know if 
the observed increase in lipid peroxidation was directly caused by the free radicals formed 
or as a consequence of some other effect induced by the activated halomethane. 
EXPERIMENT TWO 
Iron and selenium status 
As shown in Table 8 and Appendix G, Table 22, the body weights of the rats fed 
the 2% carbonyl iron diet were significantly lower than control rats fed normal dietary Fe 
levels. The Se-deficient diets and the Se supplementation in water did not affect animal 
weights. The trace amount of Se present in the Se-deficient diet was probably enough to 
prevent the development of critical Se-deficiencieny in the rats, and the dose of Se 
administered in water was probably not toxic to the animals. On the other hand, the 
ingestion of carbonyl iron probably reached toxic levels in the animals fed high-Fe diet 
because blood was observed in the animals' feces during the last weeks of the trial. 
Hemoglobin values were significantly lower in the animals with the combined 
condition of Fe overload and Se deficiency (-Se++Fe) as compared with controls (Table 8 
and Appendix G, Table 22); however, the effect was marginal (p<0.048). Low 
hemoglobin and hematocrit values have been reported under orally induced Fe overload 
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Table 8--Weight, hemoglobin, and serum iron in rats fed a 2% carbonyl iron diet deficient 
in selenium and gavaged with bromotrichloromethane. 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe 
----------------------------------------------------------------------------------------------------------
Weight, g 
f1 (101) 281 ±lOa 287 ±26a 153 ±20b 122 ±13b Control 
f2 (1.9) 263 ±8 271 ±10 137 ±16 128 ±25 Dose 
f3 (0.5) 
Hemoglobin, g/dl 
f1 (3.3) 13 ±2a 13 ±la 12 ±5ab 11 ±5b Control 
f2 (1.5) 13 ±1 14 ±2 10 ±1 6 ±1 Dose 
f3 (1.4) 
Serum Fe, 11-g/ml 
f1 (0.2) 2.5 ±o.5a 3.0 ±0.7a 3.1 ±0.2a 3.8 ±0.4a Control 
f2 (2.3) 2.7 ±1.0 3.0 ±0.6 2.7 ±1.2 1.9 ±0.6 Dose 
f3 (1.5) 
aCBrC13 (9.9 mM/ml). Dose: 5.0!11/kg/day. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same 
row with the same superscript letter are not significantly different. See Appendix G, 
Table 22. 
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combined with vitamin E and Se deficiency (Lee et al., 1981). A further statistical 
analysis of the data (Table 12) for the effect of CBrCl3 in each diet showed a significantly 
lower hemoglobin value in the -Se++Fe group, but this effect was also marginal (P < 
0.032). Bromotrichloromethane may have increased red cell hemolysis in the liver which 
may have been affected by the combined condition of Fe overload and Se deficiency 
suggested by the higher lipid peroxidation activity observed in this treatment group (Table 
10 and Appendix G, Table 24). Some animals in this group had bloody feces which may 
have accounted, in part, for the lowered hemoglobin values. Serum Fe values were not 
significantly different among treatments for either diet or CBrCl3 when the data were 
statistically analyzed by two-factor analysis of variance (Table 8 and Appendix G, Table 
20). A further statistical analysis of the data by randomized complete block design for the 
effect of CBrCl3 in each diet (Table 12) showed a significantly lowered serum Fe value in 
the -Se++Fe group. Since those animals had significantly higher levels of Fe in all the 
tissues analyzed, as described below, the possibility of Fe deficiency can be discarded. A 
more feasible explanation lies on the blood loss experienced by some animals in this group 
and also on the possibility that these animals were using serum Fe for the synthesis of 
new hemoglobin. Herbert (1975) reports a greatly reduced plasma Fe level during 
remission of hemolytic anemia, similar to the reduction observed in Fe deficiency. 
As shown in Table 9 and Appendix G, Table 23, liver Fe values were significantly 
higher in the Fe overloaded groups (13x) as compared with the normal Fe groups. Liver 
Fe in the -Se++Fe group was significantly, but marginally (p < 0.019), higher than in the 
+Se++Fe group. Further statistical analysis (Table 12) did not · show any significant 
differences among treatments for liver Fe values. 
Intestinal mucosa ( 4x) and whole intestine (3x) Fe levels were also significantly 
higher in the Fe overloaded rats as compared with the normal Fe rats (Table 9 and 
Appendix G, Table 23). 
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Table 9--Iron (J...Lg Fe/mg protein) in livers, intestinal mucosa, and whole intestines of rats 
fed a 2% carbonyl iron diet deficient in selenium and gavaged with 
bromotrichloromethane. 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe 
----------------------------------------~-----------------------------------------------------------------
Liver 
f1 (48.7) 1.2 ±0.3a 1.5 ±0.1a 15.5 ±2.9b 20.0 ±7.7C Control 
f2 ( 0.3) 1.6 ±0.4 1.4 ±0.1 16.2 ±2.0 22.1 ±3.1 Dose 
f3 ( 0.1) 
Intestinal mucosa 
f1 (67.4) 1.9 ±0.2a 2.0 ±0.4a 6.5 ±0.5b 7.1 ±0.9b Control 
f2 ( 0.8) 2.0 ±0.3 2.2 ±0.4 6.5 ±0.6 8.1 ±1.7 Dose 
f3 ( 0.4) 
Whole intestine 
f1 (129) 2.6 ±0.5a 2.6 ±0.5a 7.2 ±0.3b 7.2 ±0.6b Control 
f2 (0.1) 2.6 ±0.5 2.1 ±0.5 7.8 ±0.3 7.4 ±0.8 Dose 
f3 (0.7) 
aCBrC13 (9.9 mM/ml). Dose: 5.0J...Ll/kg/day. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same 
row with the same superscript letter are not significantly different. See Appendix G, 
Table 23. 
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Selenium-dependent GSHPx activity was significantly lower in livers (Table 10 
and Appendix G, Table 24) and intestinal mucosa (Table 11 and Appendix G, Table 25) 
of the groups fed the Se-deficient diet as compared with controls. This indicates a 
response to theSe-deficient diet (Smith et al., 1974; Hafeman et al., 1974); a similar 
observation was reported in experiment one. Hepatic Se-dependent GSHPx activity was 
significantly lower in the +Se++Fe group as compared with the +Se+Fe group (Table 10 
and Appendix G, Table 24) indicating a possible effect of Fe overload on the enzyme 
activity. This is in agreement with similar findings in livers of chronically Fe overloaded 
rats and lambs (Lee et al., 1981; Reffet et al., 1986). A similar effect was also observed 
in the intestinal mucosa of the same group of animals (Table 11 and Appendix G, Table 
25). 
In experiment one, the induced acute Fe overload resulted in a higher liver Fe 
concentration (24x) than the one chronically induced in this experiment (17x). However, 
no effect over the Se-dependent GSHPx activity in liver was observed. It could be that a 
slow and sustained build up of chronic Fe overload over time is required to observe 
lowered Se-dependent GSHPx activity. Since animals were 80g anhe beginning of this 
experiment as compared with 220g in experiment one, the age factor cannot be excluded. 
Carbonyl iron induces in rats a homogeneous distribution of Fe (in hepatocytes), 
analogous to that distribution seen in human hereditary hemochromatosis. A more 
heterogeneous deposition (in hepatocytes and Kupffer cells) has been observed in Fe 
overload induced parenterally (Bacon et al., 1986). It is possible that a lower intestinal 
and hepatic Se-depedent GSHPx activity accompanies Fe overload in human 
hemochromatosis causing a higher susceptibility toward lipid peroxidation and its negative 
effects in human health. More research is needed to further elucidate this possibility. 
A possible explanation for the observed lower Se-dependent GSHPx activity in 
rats with induced Fe overload is the presence of cysteine and histidine residues at the 
enzyme's active site (Combs and Combs, 1986). These aminoacids are highly susceptible 
Table 10--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS 
production in the livers of rats fed a 2% carbonyl iron diet deficient in selenium and 
gavaged with bromotrichloromethane. 
Dietary treatments . 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe 




0.77 ±0.04a 0.07 ±0.01b 0.72 ±0.03c 0.05 ±0.03bd Control 
0.84 ±0.09 0.09 ±0.01 0.50 ±0.06 0.04 ±0.03 Dose 









1.63 ±0.32a 1.48 ±0.17a 1.70 ±0.33a 1.73 ±0.22a Control 
1.48 ±0.21 1.68 ±0.41 1.68 ±0.23 1.8 ±0.23 Dose 
1.80 ±0.34a 1.60 ±0.15a 1.79 ±0.37a 1.99 ±0.22a Control 
1.50 ±0.26 1.88 ±0.47 1.86 ±0.14 1.83 ±0.16 Dose 













aCBrC13 (9.9 mM/ml). Dose: 5.0J.J.l/kg/day. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same 
row with the same superscript letter are not significantly different. See Appendix G, 
Table 24. 
Table 11--Glutathione peroxidase activity (GSHPx) and TBARS production in the 
intestinal mucosa of rats fed a 2% carbonyl iron diet deficient in selenium and gavaged 
with bromotrichloromethane. 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe 
GSHPx, J.!M NADP/min/mg protein 
f1 (23.1) 
f2(0.1) 
f3 ( 0.1) 
0.08 ±0.01a 0.04 ±0.01b 0.06 ±O.OOc 0.02 ±0.01b Control 
0.08 ±0.02 0.03 ±0.01 0.06 ±0.01 0.02 ±0.00 Dose 
TBARS, nM/100 mg protein 
f1 (12.6) 
f2 ( 5.0) 
f3 ( 2.6) 
125 ±26a 153 ±27a 205 ±36b 252 ±55c 




aCBrC13 (9.9 mM/ml). Dose: 5.0Jll/k:g/day. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same 
row with the same superscript letter are not significantly different. The asterisk (*) means 
that the CBrCl3 dose effect was significantly different from control. See Appendix G, 
Table 25. 
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Table 12--Hemoglobin, serum, and liver iron and liver and intestinal mucosa TBARS data 
(Tables 8, 9, 10 and 11) analyzed by randomized complete block design for 
bromotrichloro-methane dose in each diet 
Dietary treatments 














Intestinal mucosa TBARS 
1.94 
0.09 
aError line entries are MSE. 
Table f value (alpha = 0.05) 











1.40 6.89 Calculated f 
11.52 11.21 Errora 
0.59 33.09 Calculated f 
0.69 0.27 Error 
0.23 0.34 Calculated f 
6.05 34.60 Error 
0.15 5.75 Calculated f 
0.06 0.05 Error 
1.32 20.40 Calculated f 
0.17 0.42 Error 
If any calculated f is higher than the table f value, there is a significant difference between 
the compared factors. 
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to lipid peroxidation leading to the inactivation of a number of enzymes (Tappel, 1973). 
Under Fe overload, lipid peroxidation could also affect other enzymes such 
as glucose 6-phosphate dehydrogenase, a membrane bound enzyme essential for the 
generation of NADPH which is used, in turn, for the generation of reduced glutathione 
(Combs and Combs, 1986). Since GSHPx catalyzes the detoxication of hydrogen 
peroxide by the oxidation of reduced glutathione (Paglia and Valentine, 1967), the 
inactivation of glucose 6-phosphate dehydrogenase could indirectly limit the GSHPx 
activity. However, this potential effect could not be measured with the Paglia and 
Valentine method (1967) since NADPH is used in the reaction mixture as described 
Appendix B. In future research the activity of glucose-6-phosphate dehydrogenase in rats 
under acute and chronic Fe overload, as compared with that of controls, should be 
measured. 
As in experiment one, CBrCl3 did not induce any significant change in Se-
dependent GSHPx among treatments in either livers or intestinal mucosa. 
Cytochrome P-450 activity 
As shown in Table 10 and Appendix G, Table 24 the cytochrome P-450 activity 
was not affected significantly among treatments with any of the two substrates assayed. 
Accordingly, feeding a 2.5% carbonyl iron diet for a period of 10 weeks, Bacon et al. 
(1986) did not find a difference in liver cytochrome P-450 activity either. Thus, no 
interference with the required activation of CBrCl3 by the cytochrome P-450 (Recknagel 
and Glende, 1973) is expected to have occurred in this study. 
Lipid peroxidation 
Lipid peroxidation, measured as TBARS production, was significantly higher in 
the livers (Table 10 and Appendix G, Table 24) and the intestinal mucosa (Table 11 and 
Appendix G, Table 25) of all the carbonyl iron overloaded animals as compared with 
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controls. This is in accordance with reports of in vivo enhanced hepatic lipid peroxidation 
due to similar Fe overload levels (Britton et al., 1987). There was also a significantly 
higher TBARS production in the -Se++Fe group as compared with the +Se++Fe group in 
both tissues. This is probably due to the drastically lowered Se-dependent GSHPx 
activity induced during the two months of treatment. No significant difference in lipid 
peroxidation was observed between the +Se+Fe and the -Se+Fe groups. The lower 
GSHPx activity alone does not correlate with increased lipid peroxidation; the combined 
condition of Fe overload and depressed GSHPx activity is required for a significant 
generation of lipid peroxidation. The exposure to CBrCl3 did not significantly affect 
hepatic lipid peroxidation (Table 10 and Appendix G, Table 24). However, further 
statistical analysis (Table 12) indicates a marginally significant (P<0.045) hepatic effect of 
the halomethane in the -Se++Fe group of animals. Also, as shown in Table 11 and 
Appendix G, Table 25, CBrCl3 induced lipid peroxidation significantly (P<0.042) in the 
intestinal mucosa as compared with controls. Further statistical analysis (Table 12) 
showed a significant increase in lipid peroxidation, in the Se-deficient and Fe overloaded 
group (-Se++Fe). This result is in agreement with the observation in experiment one, in 




Iron and selenium status 
As shown in Table 13, Fe content was significantly lower only in the intestinal 
mucosa of the animals fed the Fe-deficient and Se-supplemented diet. A slightly lower 
intestinal mucosa level of Fe was found in the rats fed the Fe-deficient or Se-deficient 
diets. This is consistent with the reported dependence of this tissue on intraluminal Fe 
(Pascoe et al., 1983). No significant differences in liver Fe were detected among 
treatments during the relatively short period of Fe deficiency. Liver iron seems to depend 
on the whole body stores of the metal (Pascoe et al., 1983). In accordance, the 
hemoglobin values were not significantly different among the treatments (Table 13). Se-
dependent glutathione peroxidase (GSHPx) activity, an indirect parameter of the rat Se 
status (Smith et al., 1974; Hafeman et al., 1974), was significantly lower in the liver and 
intestinal mucosa of the two groups fed the Se-deficient diet as compared with the control 
groups indicating a response to theSe-deficient diet fed during the 20-day trial (Table 13). 
The combined deficiencies of Fe and Se did not add any effect to the observed differences 
in total Fe or in GSHPx activity. Previous studies have demonstrated that, in tissues such 
as human, rabbit, and rat erythrocytes and rat liver, Fe deficiency resulted in lower 
GSHPx activities (MacDougall, 1972; Rodvien et al., 1974; Lee et al., 1981). However, 
the present results indicate that, although significant differences in total Fe content in the 
intestinal mucosa were observed in animals fed the Fe-deficient diet, Fe deficiency did not 
affect intestinal mucosal GSHPx activity in either the Se supplemented or Se 
unsupplemented animals (Table 13). A more drastic deficiency of Fe may be required to 
induce such an effect on GSHPx activity. 
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Table 13--Iron, glutathione peroxidase (GSHPx) activity, and TBARS production assayed 
in the livers and small intestine mucosa, cytochrome P-450 activity in the livers, and 
hemoglobin in blood of rats fed a diet deficient in iron and/or selenium for 20 days 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se++Fe -Se++Fe 
----------------------------------------------------------------------------------------------------------
Hemoglobin, g/dl 19 ±1.1 17 ±0.6 18 ±1.2 18 ±0.6 NS 
Total iron, Jlg Fe/mg protein 
Liver 1.52 ±0.54 2.13 ±0.46 1.74 ±0.65 1.93 ±0.38 NS 
Mucosa 1.60 ±0.33 1.49 ±0.33 0.85 ±0.24 1.13 ±0.47 0.47 
GSHPx, J.l.M NADP/min/mg protein 
Liver 0.71 ±0.07 0.45 ±0.16 0.67 ±0.19 0.40 ±0.07 0.20 
Mucosa 0.07 ±0.01 0.05 ±0.01 0.07 ±0.01 0.05 ±0.01 0.01 
TBARS, nM/100 mg protein 
Liver 8.28 ±1.38 12.4 ±3.30 7.95 ±1.80 16.34 ±2.55 3.18 
Mucosa 61.9 ±15.4 114.7 ±32.3 75.4 ±18.9 114.8 ±24.9 31.9 
P-450, j.lg Para-nitrophenol/hr/mg protein 
Liver 
Substrate: EPNb 
1.36 ±0.28 1.24 ±0.47 2.14 ±0.83 1.38 ±0.52 NS 
Substrate: Para-nitroanisol 
1.13 ±0.23 0.73 ±0.25 1.23 ±0.60 0.6 ±0.37 NS 
aData are means ±standard deviation for each treatment group; n = 5 in all groups. 
Statistical significance was determined by Fishers's least significant difference test (LSD). 
Mean differences must equal or exceed the LSD value to be significant at the 5% 
probability level. NS, not statistically significant. 
hEPN means 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate. 
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Lipid peroxidation 
Lipid peroxidation, measured as TBARS production, was significantly higher in 
liver and intestinal mucosa of animals fed theSe-deficient diet (Table 13). These results 
were not reproducible in subsequent experiments which may be due to the use of diets 
with a higher content of Se ( <0.05 ppm) in those experiments. Similarly, Reiter and 
Wendel (1983), working with mouse liver, demonstrated that, in a very low Se 
supplementation range (induced with a dietary Se content of <0.01 ppm), Se plays a 
regulatory role on several hepatic enzymes other than GSHPx activity. However, using a 
dietary Se content of 0.05 ppm, Reiter and Wendel (1984) failed to reproduce their 
previous results. With the low Se content diet (0.0 1 ppm), they also observed a 30% 
increase in arachidonic acid in the liver microsomes. It might be that, in spite of the 
relatively short time of Se deficiency in this study, the low level of dietary Se fed to the 
animals ( <0.02 ppm) induced changes conducive to higher lipid peroxidation. 
Cytochrome P-450 activity 
Cytochrome P-450 activity assayed in liver homogenates did not show 
significantly different values for any of the treatment groups when data were analyzed on a 
randomized block design (Table 21). In contrast, when a two-way analysis of variance 
was applied, the activity of the enzyme assayed with the substrate para-nitroanisol was 
significantly lowered in the animals fed theSe-deficient diets. However, the effect was 
marginal (p < 0.038). These results are in accordance with the reported resistance of liver 
cytochrome P-450 to even acute deficiencies of Fe (Dallman and Goodman, 1971); as well 
as the requirement of more drastic Se deficiencies in order to affect cytochrome P-450 




As shown in Table 14 and Appendix G, Table 26, animal weights were 
significantly lower in all groups fed the 2% carbonyl iron diet. The dose of carbonyl iron 
fed was probably toxic to the animals. These results are similar to those reponed in 
experiment two after two months of feeding a similar carbonyl iron diet. Because the Se-
and/or Fe-deficient diets did not alter the rats' weights, the trace amounts of Se and Fe 
present in the semi-synthetic diet were probably sufficient to prevent the development of 
critical Se and/or Fe deficiency in the rats fed with it. Hemoglobin values were not 
significantly different among any of the treatment groups (Table 14 and Appendix G, 
Table 26), confirming the absence of severe Fe deficiency. However, as shown in Table 
14 and Appendix G, Table 26, a trend of lowered total Fe content in liver and intestinal 
mucosa was generally observed under the Fe-deficient treatments as compared with 
controls. When an orthogonal comparison of (+Se+Fe & -Se+Fe) vs (+Se-Fe & -Se-Fe) 
for main treatment combinations was made, liver Fe was found to be significantly lower in 
the rats fed Fe-deficient diet. The high-Fe treatment resulted in a significantly higher Fe 
content in all the tissues evaluated as compared with controls: Liver (9 x), intestinal 
mucosa (4x), and whole intestines (3x) (Table 14 and Appendix G, Table 26). This is in 
agreement with the described deposition of Fe associated with Fe overload in practically 
all body areas, especially in spleen and liver, as described by Harris and Kellermeyer 
(1974). Hemoglobin values (Table 14 and Appendix G, Table 26) were not significantly 
different among Fe overloaded animals as compared with controls which is consistent 
with the regulation of red blood cell production by the tissue oxygenation needs rather 
than by the excess of Fe (Harris and Kellermeyer, 1974). Serum Fe was not evaluated in 
the Fe overloaded animals, but in experiment two rats fed a similar carbonyl Fe diet during 
2 months did not show a significant difference in serum Fe values among normal Fe 
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Table 14--Weight, hemoglobin, and hepatic and intestinal iron in rats fed a diet deficient in 
selenium and iron or fed a 2% carbonyl iron diet deficient in selenium 
Dietary treatment 
Measures +Se+Fe -Se+Fe +Se-Fe -Se-Fe +Se++Fe -Se++Fe 
Weight, g 
f (98.0) 357 ±21a 358 ±19a 364 ±22 351 ±29 192 ±15b 170 ±15b 
Hemoglobin, g/dl 
f (1.1) 15 ±2a 15 ±2a 14 ±1a 13 ±1a 15 ±1a 15 ±2a 





1.7 ±0.4a 1.6 ±0.2a 0.6 ±0.1 0.6 ±0.1 15.1 ±0.9b 14.9 
f (113.0) 1.6 ±0.3a 1.4 ±0.2a 0.9 ±0.2 0.8 ±0.1 7.1 ±1.1b 6.0 ±0.8c 
Whole intestine 
f (60.2) 2.6 ±0.4a 2.6 ±0.4a 2.4 ±0.3 2.8 ±0.2 7.5 ±0.9b 7.2 ±1.3b 
Data are means ±standard deviation for each treatment group; n = 5 rats in all groups. 
Table f value (alpha 0.05): f (5,24) = 2.62. If any calculated f is higher than the table f 
value, there is a significant difference between the compared factors. Values in the same 
row with the same superscript letter are not significantly different based on orthogonal 
comparisons. See Appendix G, Table 26. 
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supplemented animals and Fe overloaded animals. However, rats with acute Fe overload 
due to injections of Fe dextran had significantly higher values of serum Fe as compared 
with controls (experiment one). The four dietary groups that received CBrCl3 did not 
experience significant changes in hemoglobin or serum Fe among them due to the diet or 
due to the CBrCl3 (Table 15 and Appendix G, Table 27). However, the orthogonal 
comparisons for main treatment effects showed significantly lower hemoglobin and serum 
Fe values in the Fe-deficient groups as compared with controls (Appendix G, Table 27). 
Selenium status 
Se-dependent GSHPx activity, an indirect parameter of Se status (Smith et al. , 
1974; Hafeman et al., 1974), was significantly depressed in liver and intestinal mucosa of 
the groups fed theSe-deficient diet as compared with controls (Table 16 and Appendix G, 
Table 28). This result is consistent with those described in experiments one, two and 
three under different periods of induced Se-deficiency. Significantly decreased hepatic Se-
dependent GSHPx activity was found in the Fe overloaded and Se supplemented rats as 
compared with controls (+Se+Fe vs +Se++Fe), (Table 15 and Appendix G, Table 28). 
These results confirm those of experiment two also observed under chronic Fe overload. 
They are in agreement with similar reports in lambs (Reffet et al., 1986) and rats (Lee et 
al., 1981) with orally induced Fe overload. A significantly lowered activity of Se-
dependent GSHPx was also observed in the intestinal mucosa of the Fe overloaded rats as 
compared with controls ( +Se+Fe vs +Se++Fe). The lowered activity of the intestinal 
peroxidase was also marginally significant in the Fe overloaded and Se-deficient animals 
as compared with controls (-Se+Fe vs -Se++Fe) (Table 16 and Appendix G, Table 28). 
In experiment two, a similar effect of chronic Fe overload over the hepatic and intestinal 
Se-dependent GSHPx was observed. Acute Fe overload induced with Fe dextran 
injections (experiment one) did not induce any changes on Se-dependent GSHPx. 
Chronic induction of Fe overload seems to be required for the modification of GSHPx 
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Table 15--Hemoglobin and serum iron in rats fed a diet deficient in selenium and /or iron 
and gavaged with bromotrichloromethane 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se-Fe -Se-Fe 
Hemoglobin, g/dl 
f1 (3.0) 15 ±1.7a 15 ±1.6a 14 ±o.sa 13 ±0.5b Control 
f2 (0.4) 15 ±2.2 16 ±0.7 15 ±1.6 13 ±0.9 Dose 
f3 (0.5) 
Serum Fe, j..!g/ml 
f1 (3.2) 3.5 ±0.7a 3.0 ±0.4a 2.4 ±0.5b 2.7 ±0.3b Control 
f2 (0.01) 3.3 ±0.5 3.1 ±0.6 2.8 ±0.6 2.3 ±0.4 Dose 
f3 (0.4) 
acBrC13 (9.9 mM/ml). Dose: 5j..!l/kg. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Values in the same row with the same superscript letter are not 
significantly different based on orthogonal comparisons. See Appendix G, Table 27. 
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activity in both, liver and intestinal mucosa. Since animals were 80g at the beginning of 
this experiment as compared with 220g in the experiment in which acute Fe overload was 
induced, the age factor cannot be excluded. Iron deficiency did not induce any significant 
difference in Se-dependent GSHPx activity in the liver or intestinal mucosa of either Se 
supplemented or Se unsupplemented animals (Table 16 and Appendix G, Table 28). 
Previous studies have demonstrated that in tissues such as human, rabbit, and rat 
erythrocytes and rat liver, Fe deficiency resulted in lower GSHPx activities (MacDougall, 
1972; Rodvien et al., 1974; Lee et al., 1981). Again, a more drastic Fe deficiency may be 
necessary to induce a significant change in the peroxidase activity. 
Bromotrichloromethane did not have a significant effect on Se-dependent GSHPx 
activity in liver or intestinal mucosa in any of the four groups of rats treated (Table 17 and 
Appendix G, Table 29). This could be due to the fact that the animals were exposed just 
once to the halomethane and killed four hours later not allowing enough exposure time to 
the challenger for any significant change in the peroxidase activity to take place. In 
experiment one, CBrCl3 gavaged to rats at a lower dose for five consecutive days until 
sacrifice did not change significantly the Se-dependent GSHPx either. 
Cytochrome P-450 activity 
As shown in Table 16 and Appendix G, Table 28, liver cytochrome P-450 activity 
assayed with the substrate, EPN, was not significantly different from the controls for any 
of the dietary treatments. When assayed with para-nitroanisol, the changes on enzyme 
activity were marginally significant for the dietary treatments. The orthogonal comparison 
for main treatment effects between (+Se+Fe & +Se++Fe) vs (-Se+Fe & -Se++Fe) and(-
Se++Fe) vs (+Se ++Fe) showed a significantly lower cytochrome P-450 activity in theSe-
deficient groups as compared with the Se supplemented groups. There is evidence that in 
severe Se deficiency there may be decreases in some forms of hepatic cytochrome P-450, 
especially when inducers of the enzyme such as phenobarbital are administered to the rats. 
Table 16--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS 
production in rats fed a 2% carbonyl iron semi-synthetic diet deficient in selenium. 
Dietary treatment 
Measures +Se+Fe -Se+Fe +Se-Fe -Se-Fe +Se++Fe -Se++Fe 
GSHPx, ~M NADP/min/mg protein 
Liver 




f (25.2) 0.15 ±.02a 0.05 ±.Olb 0.17 ±.06 0.05 ±.Olb 0.08 ±.02b 0.01 ±.ooc 
P450, ~g Para-nitrophenol /hr/mg protein 
Liver 
Substrate: para-nitroanisol 
f (2.7) 1.47 ±.30 1.32 ±.28 1.57 ±.30 1.65 ±.22 1.67 ±.14a 1.24 ±.lib 
Substrate: EPNa 
f (1.2) 1.79 ±.19a 1.69 ±.13a 1.78 ±.28a 1.83 ±.08a 1.83 ±.lOa 1.61 ±.19a 
TBARS, nM/100 mg protein 
Liver 
f (54) 12±3a 13 ±2a 11 ±4 10±3 134 ±26b 246 ±66ac 
Intestinal mucosa 
f (18) 65 ±21a 69 ±2Ia 60±15 57 ±25 150 ±4b 197 ±40ac 
aEPN: 0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate. 
Data are means ±standard deviation for each treatment group; n = 5 rats in all groups. 
Table f value (alpha 0.05): f (5,24) = 2.62. If any calculated f is higher than the table f 
value, there is a significant difference between the compared factors . Values in the same 
row with the same superscript letter are not significantly different based on orthogonal 
comparisons. See Appendix G, Table 28. 
61 
Selenium seems to be required for the maintenance of one or more forms of cytochrome P-
450 (Burk and Correia, 1981). However, Reiter and Wendel (1983, 1984) did not 
observe any significant change in the cytochrome P-450 activity assayed with aniline 
(hydroxylation) or with aminopyrine (demethylation) after 2 and 6 months of low dietary 
Se (0.01 ppm) treatment. They detected, instead, a 240% increase in the cytochrome P-
450 activity when assayed with 7-ethoxycoumarin (de-ethylation). These authors 
observed that the 0.01 ppm dietary Se level was a requirement for the induction of the 
enzyme; with a diet of 0.05 ppm Se, they failed to induce any statistically significant 
changes. These reports indicate that the overall influence of Se on xenobiotic metabolism 
is likely to be very complex. 
Iron overload did not change significantly the cytochrome P-450 activity. This is 
in agreement with Bacon et al. (1986) who did not observe a significant change in 
cytochrome P-450 when feeding rats with a chow diet supplemented with 2% carbonyl 
iron for 5 months. In experiments one and two, Fe overload did not induce any important 
change in the cytochrome P-450 activity either. The lack of effect of the Fe-deficient diet 
on the cytochrome P-450 activity (Table 16 and Appendix G, Table 28) is consistent with 
the reported resistance of the cytochrome to acute deficiency of Fe (Dallman and 
Goodman, 1971 ); even though Fe status affects the P-450 content in other rat tissues 
(Dhur et al., 1989). Since the effect of Se deficiency on the cytochrome P-450 assayed 
with para-nitroanisol is too small to affect meaningfully the activation of CBrCl3 by the 
enzyme, no interference with the required activation of CBrCl3 by the liver cytochrome P-
450 (Recknagel and Glende, 1973) is expected. Due to the different nature of the 
intestinal mucosa as compared with that of liver, the activation of CBrCl3 in the intestinal 
tract might not depend on cytochrome P-450 as critically as in liver. 
Not only the intestinal wall but also the intestinal microflora may transform 
xenobiotics enzymatically (Vainio and Hietanen, 1980). The activation of several kinds of 
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xenobiotics, some of them procarcinogens, has also been reported to be associated with 
cooxidation with prostaglandin synthase (PHS) during oxidation of arachidonic acid 
(Ross, 1985). PHS activit)' is relatively high in many extra-hepatic tissues which are low 
in mixed function oxictase, such as the intestinal mucosa. Thus, it has been proposed that 
PHS could be an alternative or additional enzyme system for the metabolic activation of 
compounds which exhibit extra-hepatic toxicity and carcinogenicity (Krauss and Eling, 
1984; Ross, 1985). In the rat, the total intestinal cytochrome P-450 is about 1.6% of the 
level in liver (0.1 vs 0.9 nmoVmg microsomal protein) (Vainio and Hietanen, 1980). It 
has been suggested that intestinal enzyme activities observed in rats on noJ!Ilallaboratory 
chow are due to exogenous factors in the diet which induce enzymes present at very low 
levels (Wattenberg, 1971). Under semi-synthetic diets as used in these studies, some of 
the enzymatic activities are either absent or require very sensitive methods of detection 
(Wattenberg, 1971). We did not measure the activity of P-450 on intestinal mucosa 
because it was below the detection limit of the method employed. 
Lipid peroxidation 
Lipid peroxidation, measured as TBARS production, was significantly higher in 
the livers and the intestinal mucosa of the Fe overloaded groups (Table 16 and Appendix 
G, Table 28). This is in accordance with reports of in vivo enhanced liver lipid 
peroxidation due to chronic Fe overload (Britton et al., 1987). Similar results were 
obtained with Fe overloaded animals induced with injected iron dextran (experiment one) 
and with carbonyl iron (experiment two). Se-deficient and Fe overloaded rats (-Se++Fe), 
when compared with Se supplemented and Fe overloaded animals (+Se++Fe), had 
significantly higher TBARS production in liver and intestinal mucosa. This probably 
reflects the drastic reduction in GSHPx activity reached after three months of dietary Se 
deficiency. Similar results were observed in experiment two in Fe overloaded rats fed a 
similar carbonyl iron diet for two months. Animals fed the marginal Fe content diet did 
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not show a higher susceptibility to lipid peroxidation (Table 16 and Appendix G, Table 
28). However, Fe deficiency could favor the induction of lipid peroxidation in liver and 
other organs. Fe deficiency can affect the metabolism of lipids and can also modify the 
enzymatic activity of important lines of cellular defense against lipid peroxidation. It has 
been reported that Fe deficiency may induce hypertriglyceridemia and fatty livers in pups 
of Fe-deficient rats and Fe supplementation reverses the lipid accumulation (Bartholmey 
and Sherman, 1985). A feasible explanation relies in the requirements of Fe for the 
synthesis of carnitine, an essencial cofactor for oxidation of normal fatty acids 
(Bartholmey and Sherman, 1985). Iron has also an integral role in the production of 
unsaturated fatty acids; because in rats fed an Fe-deficient diet, the ratio monounsaturated 
to saturated fatty acids in tissue lipids is reduced. This seems to be a consequence of a 
reduction in the activity of a desaturase Fe-containing enzyme complex found in several 
tissues (Larkin et al., 1986). Iron deficiency can also lower the enzymatic activity of 
GSHPx and catalase (Rodvien et al., 1974; MacDougall, 1972) and reduce the normal 
cellular defense against lipid peroxidation. Bromotrichloromethane did not enhance lipid 
peroxidation among the four dietary treatment groups evaluated (Table 17 and Appendix 
G, Table 29). At the marginal level of Fe intake, no significant susceptibility to induced 
lipid peroxidation by the halomethane was observed as compared with that of controls; a 
more drastic Fe deficiency or greater exposure to the halomethane may be required to 
induce such a response. 
The lowered Se-dependent GSHPx activity alone or in combination with Fe 
deficiency, did not favor the induction of lipid peroxidation by the gavaged CBrCI3. 
Anemia has been the main public health concern associated with Fe deficiency. However, 
long before anemia can take place, a lowered level of Fe can be noticed in the body Fe 
reserves measured as serum ferritin (Mertz, 1981). This initial Fe deficiency is 
accompanied by lowered activities of many important enzymes as commented before. This 
Table 17--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS 
production in rats fed a diet deficient in selenium and/or iron and gavaged with 
bromotrichloromethane. 
Dietary treatments 
Measures +Se+Fe -Se+Fe +Se-Fe -Se-Fe 





0.73 ±0.10a 0.07 ±0.01b 0.78 ±0.06a 0.09 ±0.01b Control 
0.83 ±0.04 0.08 ±0.01 0.70 ±0.08 0.08 ±0.01 Dose 
Intestinal tract 
f1 (13) 0.15 ±0.02a 0.05 ±0.01b 0.17 ±0.06a 0.05 ±0.01b Control 
f2 (4.2) 
f3 (0.96) 
0.08 ±0.01 0.04 ±0.00 0.13 ±0.05 0.05 ±0.01 Dose 
P-450, Jlg Para-nitrophenol/hr/mg protein 
Liver 
Substrate: para-nitroanisol 
f1 (0.34) 1.47 ±0.30a 1.32 ±0.29a 1.57 ±0.30a 1.65 ±0.20a Control 
f2 (1.30) 1.41 ±0.34 1.37 ±0.25 1.31 ±0.19 1.38 ±0.18 Dose 
f3 (0.40) 
Substrate: EPNb 
f1 (0.31) 1.79 ±0.20a 1.69 ±0.13a 1.78 ±0.28a 1.83 ±0.08a Control 
f2 (1.07) 1.59 ±0.24 1.62 ±0.35 1.71 ±0.26 1.74 ±0.11 Dose 
f3 (0.10) 
TBARS, nM/100 mg protein 
Liver 
f1 (0.42) 12±3a 13 ±2a 11 ±4a 10 ±3a Control 
f2 (1.07) 13 ±4 16 ±4 13 ±2 13 ±5 Dose 
f3 (0.12) 
Intestinal mucosa 
f1 (0.93) 65 ±21a 69 ±21a 60 ±15a 57 ±25a Control 
f2 (3.93) 65 ±13 102 ±55 125 ±32 74±29 Dose 
f3 (0.91) 
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aCBrC13 (9.9 mM/ml). Dose: 5J.!l/kg. Data are means ±standard deviation for each 
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) = 
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is 
higher than the respective table f value, there is a significant difference between the 
compared factors. Values in the same row with the same superscript letter are not 
significantly different based on orthogonal comparisons. See Appendix G, Table 29. 
bEPN: 0-ethyl-0-( 4-nitrophenyl) phenylphosphonothioate. 
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is particularly noticeable in tissues with a fast cell turnover rate such as in the intestinal 
mucosa (Pascoe et al., 1983). However, the exact impact in human health of those altered 
enzymatic activities is not known. 
Since not enough Fe overloaded animals survived the three months of treatment, 
CBrCl3 was not tested in the Fe overloaded groups. However, in accordance with the 
results discussed in experiments one and two, the combination of Fe overload and Se 
deficiency might have rendered these animals more susceptible to lipid peroxidation 




Dietary Se-deficiency alone or in combination with Fe overload or marginal 
dietary Fe intake was induced in rats. Two models of experimental Fe overload induction 
were used: oral ingestion of carbonyl iron, which causes hepatic Fe distribution in a 
pattern analogous to that seen in human hepatocytes due to hereditary hemochromatosis; 
and intramuscular injections of iron dextran, which causes a more homogeneous 
deposition of Fe in hepatocytes and Kupffer cells. Both injected iron dextran and oral 
carbonyl iron are used in therapy for Fe-deficiency anemia. The induced Fe overload was 
reflected by a higher Fe levels in the liver and intestines of the treated animals. Higher in 
vivo lipid peroxidation, measured as TBARS, was observed in both tissues from the Fe 
overloaded rats. Lipid peroxidation was even higher in animals with Fe overload and Se-
deficiency chronically induced over periods of two and three months as compared with 
animals with acute Fe overload and Se deficiency induced over a period of 20 days. 
Chronically induced Fe overload was required for the reduction of the Se-dependent 
GSHPx activity in the liver, in agreement with previous reports. The first observation of 
this phenomenon in the intestinal mucosa of those animals is reported here. Under acute 
Fe overload no change in the Se-dependent GSHPx activity was observed in liver or 
intestinal mucosa. This suggests the possiblility that patients with hereditary 
hemochromatosis, who have a similar liver Fe distribution than that due to chronic Fe 
overload, may also experience a lowered GSHPx activity which would increase their 
susceptibility to lipid peroxidation even more than would be anticipated from their 
increased tissue Fe levels alone. More research is required to elucidate further this 
possibility along with the potential need for increased Se intake to counteract such an 
effect. Low doses of CBrCl3 elevated the TBARS production in the intestinal mucosa of 
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theSe-deficient and Fe overloaded animals, the group of animals most susceptible to lipid 
peroxidation. The first in vivo observation of the extrahepatic action of this compound is 
reported here; this in agreement with previous in vitro evidence of its action in intestinal 
tissue. The possibility of an increased susceptibility to lipid peroxidation initiators in the 
environment among people with abnormally high levels of tissue Fe should be 
contemplated and a strategy for its evaluation and prevention should be developed. The 
marginal Fe deficiency induced did not affect Se-dependent GSHPx activity or CBrCl3 
induced lipid peroxidation. It is possible that a more drastic Fe-deficiency might affect 
GSHPx activity and should be considered in further studies. 
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A. Soak glassware overnight in 6 N hydrochloric acid. 
B. Soak glassware overnight in 25 mM EDTA, tetrasodium salt (optional). 
C. Rinse 12 times with deionised water. 
D. Dry thoroughly. 
Reagents 
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A. 0.02 % ascorbic acid in 0.2 N hydrochloric acid (to reduce ferric iron to ferrous 
iron). 
1) In a 100 ml volumetric flask dissolve 0.02 g ascorbic acid (Baker, reagent grade) 
in a small quantity of deionised water. 
2) Add 1.67 ml concentrated hydrochloric acid and dilute to volume. 
3) Make fresh every day and store at 4 C. 
B. 10% ammonium acetate buffer. 
Dissolve 10 g ammonium acetate (Baker analyzed) in 100 ml deionised water of final 
volume. 
C. 1 mM ferrozine reagent (3-(2-Pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4,-triazine) 
In a volumetric flask dissolve 0.051 g ferrozine in 100 ml deionised water. Keep it 
in the dark and refrigerate. 
Iron standard 
A. Dissolve 100.0 mg electrolytic iron in concentrated hydrochloric acid and dilute to 1 
liter with deionised water. Make serial dilutions of this stock solution to prepare a 
calibration curve. 
B. Prepare a blank with deionised water instead of sample or standard. 
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C. Use blank to set absorbance to zero. 
D. Plot standard curve: A 562 vs ~g Fe. 
Typically, a sample which has a total of 5 ~g Fe (i.e. 5 ~g/5 ml) has an absorbance of 
0.5; 10 ~g Fe has an absorbance of 1.0; etc. 
Sample digestion 
A. Weigh 1 g sample of diet; or pipette a 1 ml sample of homogenate into a 50 ml 
Erlenmeyer flask. 
B. Add a pyrex glass bead, and 20 ml nitric acid. Heat to dryness and add 5 ml 
hydrogen peroxide. Heat it again to dryness. Dilute appropriately with hydrochloric 
acid and take the 0.5 aliquot required for the iron analysis. 
Procedure 
A. Add 0.5 ml of digested sample solution. 
B. Add 0.38-0.50 ml 12 N sodium hydroxide 
C. Check acidity with pH paper on one of the triplicates. This assay must be conducted 
at a nearly neutral pH (6-7). 
D. Add 1.35 ml ascorbate solution. Mix and let stand for 15 min. 
E. Add 1.00 ml acetate buffer solution. Mix well. 
F. Add 1.35 ml Ferrozine reagent. Mix well. 
G. Make up volume to 5 ml with deionised water. 
H. Wait 30 min. Vortex the tubes and read absorbance at 562 nm. 
(Best results are obtained in samples containing 1-50 ~g Fe). 
Principle 
Organic molecules containing the atomic configuration 
HH 
-N=C-C=N-
react as bidentate ligands with ferrous ion to give colored complex species. Ferrozine 
reacts with divalent iron to form a stable magenta complex species soluble in water. 
Reagents 
APPENDIXB 
GLUT A TIIIONE PEROXIDASE ACITVITY DETERMINATION 
(Paglia and Valentine, 1967) 
A. 0.05 M potassium phosphate buffer pH 7. 
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Mix equal volumes of monobasic potassium phosphate (6.8 g in 500 ml deionised 
water) and dibasic potassium phosphate (8.71 gin 500 ml deionised water) containing 
5 mM EDTA (1.46 grin 1liter buffer). Total1liter. Check pH. 
B. 8.4 mM B-Nicotinamide adenine dinucleotide phosphate, reduced form (NADPH). 
In a 10 ml volumetric flask, dissolve approximately 79.2 mg NADPH in 10 ml 
deionised water. Before weighing the NADPH correct for atomic weight of sodium, 
23, and atomic weight of hydrogen, 1. Similarly, adjust the molecular weight (m.w.) 
of water of hydration. Adjust for purity: m.w. divided by the % purity. When 
preparing small quantities, the concentration per ml desired, C, should be multiplied 
by the number of milliliters of reagent required and an exact weighing made of 
approximately this quantity. The volume of water to be added V, is then obtained by 
dividing the exact quantity that has been weighed, W by the concentration per 
milliliter desired: V=W/C. 
C. Glutathione reductase (GSSG-R). 
Yeast crystalline, 100 e.u. per mg protein in 1 ml. Calbiochem, Los Angeles, CA. 
D. 1.125 M sodium azide. 
Dissolve 7.31 g sodium azide in 100 ml deionised water. 
E. 0.15 M reduced glutathione (GSH). In a 10 ml volumetric flask, dissolve 0.461 g 
GSH in 10 ml deionised water. 
F. 2.2 mM hydrogen peroxide. 
Dilute 5 ml 30 % hydrogen peroxide to 50 ml with deionised water. Take exactly 5 ml 
of the diluted hydrogen peroxide and dilute it to 2000 ml. 
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Sample 
LIVER: Dilute 0.1 mlliver supernatant (from homogenate centrifuged at 10.000 g, as 
described in chapter ill) in 5 m1 buffer. 
G.I. MUCOSA: Dilute 0.1 ml gastrointestinal mucosa supernatant (from homogenate 
centifugued at 10.000 g, as described in chapter ill) in 0.2 m1 buffer. 
Procedure 
A. In a 10 m1 disposable culture tube, place 2.8 m1 of reaction mixture (2.58 m1 buffer, 
0.1 m1 NADPH, 0.01 m1 GSSG-R, 0.01 m1 sodium azide, and 0.1 m1 GSH) 
B. Add 0.1 m1 sample. 
Let it equilibrate at 20 C for 5 min. 
C. Add 0.1 m1 substrate (To initiate the reaction). 
D. Read absorbance at 340 nm. The conversion of NADPH to NADP is followed 
spectrophotometrically by continuous recording of the change in absorbance of the 
system at 340 nm between 2 and 4 minutes after initiation of the reaction, employing a 
cuvette with a 1 em light path. 
E. Enzyme units were defined as the number of micromoles of NADPH oxidized per 
minute per mg protein; and were calculated on the basis of a molar absorptivity for 
NADPH at 340 mu of 6.22 x 10-6. Protein content of the samples was determined by 
Bradford's method (Bradford,1976) using bovine serum albumin as standard. 
F. Control. Human blood hemolysate (1 m1 whole blood, 5 m1 saline, 6 ml Drabkins's 
reagent, and 16 ml deionised water) was prepared, and 0.1 m1 hemolysate instead of 
sample was added to the reaction mixture as a control. Human blood GSHPx activity 
is 30.82 + 4.65 IU/g Hb (Beutler, 1984). Hemoglobin content in whole blood was 
determined spectrophotometrically as cyanmethemoglobin (Crosby et al., 1954). 
Reactions 
GSHPx GSSG-R 
2 GSH + H202 --------- H20 + GSSG --------- 2 GSH 
NADPH NADP 
APPENDIXC 
LIPID PEROXIDA TION: DETERMINATION OF TIIIOBARTURIC ACID 
REACTIVE SUBSTANCES (TBARS) 
(Buege and Aust, 1984) 
Reagents 
A. Stock TCA-TBA-HCl reagent. 
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1) Add 15 g (15 % w/v) trichloroacetic acid (TCA) to a 100 ml volumetric that 
contains approximately 50 ml deionised water. 
2) Add 0.375 g (0.375 % w/v) thiobarbituric acid, (4,6-Dihydroxy-2 
-thiopyrimidine), TBA. 
3) Add 2.059 ml 0.25 N hydrochloric acid (HCl). Take it to volume. It may be 
mildly heated to assist · in the dissolution of TBA. 
B. Tris potassium chloride buffer (150/25 mM); pH 7.5 
1) Mix 11.17 5 g potassium chloride in a 1000 ml volumetric flask with some 
distilled water. 2) Add 3.028 g tris (Hydroxymethyl) aminomethane and make it 
to volume. Adjust pH. 
Procedure 
A. Place 440 Jll Tris potassium chloride buffer in a 10 ml disposable culture tube. 
B. Add 60 Jll1% butylated hydroxytoluene (BHT) . Prepared as 0.1 g BHT in 10 ml 
ethanol. 
C. Add 60 Jll sample (supernatant from homogenate centrifuged at 10.000 g as described 
in chapter III). 
D. Blank: Substitute sample with buffer. 
E. Add 1500 Jll stock reagent. 
F. Mix thoroughly. 
G. Incubate 15 min in a boiling water bath. 
H. Cool under running water. 
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I. Centrifuge at 2000 g for 10 min. 
J. Blank: Substitute sample with buffer. 
K. Read in a spectrophotometer at 535 nm. The absorbance of the sample is determined 
at 535 nm against a blank that contains all the reagents minus the sample. The 
malondialdehyde concentration of the sample can be calculated using an extinction 
coefficient of 1.56 x 105 M-1 cm-1. Units are expressed as nM TBARS/100 mg 
protein. Protein content of the samples was determined by the Bradford method, 
using bovine serum albumin as standard (Bradford, 1976). 
L. To determine potential TBARS formation during sample storage, four supernatent 
samples (S 12) were analyzed after 1 and 8 days of storage, four different 
supernatent samples (S 12) were analyzed after 1 day and 1 month of storage, and 
four additional supernatent samples (S12) were analyzed after 1 day and 2 months of 
storage. The data were analyzed by the t-dependent statistical test. Samples analyzed 
after 1 day and 8 days of storage averaged 448 ±174 and 437 ±125 nM TBARS/ml 
cytosol (t-dep=0.10, NS), respectively. Samples analyzed after 1 day and 1 month 
of storage averaged 178 ±178 and 174 ±180 nM TBARS/ml cytosol (t-dep=.01, 
NS), respectively. And, samples analyzed after 1 day and 1 month of storage 
averaged 207 ±235 and 194 ±220 nM TBARS/ml cytosol (t-dep=.08, NS), 
respectively. It was concluded that storage time did not increase supernatent TBARS 
levels in this procedure. 
Principle 
Malondialdehyde, formed from the breakdown of polyunsaturated fatty acids, serves 
as a convenient index for determining the extent of the peroxidation reaction. It has 
been identified as the product of lipid peroxidation that reacts with thiobarbituric acid 
to give a red species with an absorbance at 535 nm. 
Reagents 
APPENDIXD 
DETERMINA TIN OF CYTOCHROME P-450 ACTIVITY 
(Kinoshita et al., 1966) 
A. 0.1 M phosphate buffer pH 7 .8. 
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1) In a 100 ml volumetric flask dissolve 1.42 g of dibasic anhydrous sodium 
phosphate with deionised water. 
2) Adjust to pH 7.8 with concentrated hydrogen chloride. 
B. Cofactor solution. 
1) B-Nicotinamide adenine dinucleotidphosphate (NADP). Dissolve 100 mg 
NADP in 10 ml deionised water. 
2) Glucose 6-phosphate. Dissolve 100 mg glucose 6-phosphate in 10 ml deionised 
water. 
3) Mix 1) and 2) in equal amounts. 
C. Substrates 
1) Stock solution. Prepare a 20 % ethanol and 80 % propylene glycol 
(propanediol) solution. 
2) 0-ethyl, 0-(4-nitrophenyl) phenylphosphonothioate; (EPN) solution. Dissolve 7 
mg EPN in 1 ml stock solution. Immediately before the initiation of the 
experiment, mix one part of EPN solution to 9 parts phosphate buffer. 
3) para-nitroanisol solution. Dissolve 14 mg para-nitroanisol in 1 ml stock solution 
Immediately before the initiation of the experiment mix one part of para-nitroanisol 
solution to 9 parts phosphate buffer. 
D. Enzyme preparation. Use 0.1 mlliver homogenate. 
E. 0.5 M Glycine buffer. 
1) Dissolve 0.375 g glycine in 10 ml deionised water. 
2) Adjust to pH 9.5 with sodium hydroxide. 
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F. Standard curve (for both substrates) 
1) In a 10 ml volumetric flask dissolve 4.2 mg para-nitrophenol in deionised water. 
Take 1 ml of this solution and dilute it to 5 ml in a volumetric flask. 
3) Place 25 1.1.1, 50 1.1.1, 75 1.1.1 and 100 1.1.1 of the above solution in 10 ml disposable 
culture tubes. Take each tube to a volume of 1 ml with deionised water. 
4) Add 2.5 ml acetone and 0.2 ml glycine buffer. 
5) Read in a spectrophotometer at 410 nm. 
Enzyme assay 
1) Add 0.5 ml buffer to a 10 ml disposable culture tube. 
2) Add 0.2 ml of cofactor solution. 
3) Add 0.2 ml substrate EPN solution or substrate para-nitroanisol solution. 
4) Add 0.1 ml homogenate. 
5) Incubate 30 min in a shaker at 37.5 C. 
6) Add 2.5 ml acetone. 
7) Add 0.2 ml glycine buffer. 
8) Mix well. 
9) Centrifuge at 3000 rpm for 10 min. 
10) Read at 410 nm. 
11) For both substrates, the enzyme activity is expressed as micrograms of p-
nitrophenol formed from the substrate/hr/mg protein. Protein was determined by 
the Bradford method, using bovine serum albumin as standard (Bradford, 
1976). 
Principle 
The hepatic cytochrome P-450 system of enzymes present in the liver homogenate, 
catalizes the oxidation of EPN and the 0-dealkylation of para-nitroanisole, 
metabolizing these substrates into para-nitrophenol; which is measured in each case 
as l.l.g para-nitrophenol produced /mg protein (homogenate)/h. 
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APPENDIXE 
CY ANME'IHEMOGLOBIN METIIOD FOR DETERMINING BLOOD HEMOGLOBIN 
(Crosby et al., 1954) 
Drabkin's Reagent Preparation 
One gram sodium bicarbonate, 52 mg potassium cyanide, and 198 mg potassium 
ferricyanide were dissolved and diluted to 1000 rnl in a volumetric flask with distilled 
water. The solution was stored in a dark brown glass container at room temperature. 
Procedure 
1) Twenty microliters of unclotted blood was pi petted into 5 ml Drabkin's reagent. 
2) The solution was mixed well and allowed to set 30 min. Absorbance was read at 
540 nm in a spectophotometer. 
3) Hemoglobin concentrations were determined from the standard curve derived 
from commercial hemoglobin standards (Fischer Scientific Company, 
Diagnostics Division, Orangeburg, New York.) 
Rea~ents 
APPENDIXF 
PROTEIN DETERMINATION IN TISSUE HOMOOENA TES 
(Bradford, 197 6) 
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A . Protein Reagent. Dissolve 100 mg of coomassie brilliant blue G-250 in 50 ml of 95 
%ethanol. Dissolve with continuous stirring for 2-3 hr. To this solution add 100 ml 
of 85 % phosphoric acid. Dilute to one liter and shake or stir for 1 hr. Before use, 
filter it with double layered #1 filter paper. 
B . Buffer, 0.1 M phosphate buffer, pH 7 .8. Add 1.42 gr anhydrous dibasic sodium 
phosphate to 100 ml deionised water. Mix. Adjust to pH 7.8 with concentrated 
hydrochloric acid. 
C. Protein standard. In a volumetric flask, dissolve 10 mg of bovine serum albumin 
(BSA) in 10 ml buffer. Pipette 15, 25, 50 and 75 ~1 dissolved BSA in 10 ml 
disposable culture tubes. Adjust to 100 ~1 with buffer. Proceed with the steps for the 
protein assay described below. Measure the absorbance at 595 nm against the reagent 
blank (zero BSA). Plot ~g protein against absorbance to generate a standard curve 
for use in determining protein in unknown samples. 
Sample dilution 
A. Liver homogenate. Take 50 ~1 homogenate (prepared as described in chapter ill) and 
dilute with 5 ml buffer. 
B . Intestinal homogenates. Take 50 ~I of intestinal mucosa homogenate (prepared as 
described in chapter III) and dilute with 1 ml buffer. The same procedure was used 
for the dilution of whole intestine homogenate. 
C . Liver supernatant. Take 25~1 of liver supernatant (prepared as described in chapter 
III) and add 2.5 ml buffer. 
D. Gastrointestinal mucosa supernatant. Take 100 ~I intestinal mucosa supernatant and 
add 2.0 ml buffer. 
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Protein assay 
Pipette 100 J...Ll sample in 10 ml disposable culture tubes. Add 5.0 ml of filtered 
protein reagent to each tube. After 2 minutes and before an hour, vortex the test tube 
and read the absorbance against the reagent blank at 595 nm. 
Principle 
The method involves the binding of coomassie brilliant blue G-250 to protein. The 
binding of the dye to protein causes a shift in the absorption maximum of the dye 
from 465 to 595 nm, and it is the increase in absorption at 595 nm which is 
monitored. This assay is very reproducible and rapid with the dye binding process 
virtually complete in approximately 2 min with good color stability for 1 h. 
APPENDIXG 
TABLES OF ORTHOGONAL COMPARISONS 
Table 18--0rthogonal comparisons as tests of significance for weight, hemoglobin, and 
serum iron (Table 3) 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
( +Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
Control vs dose II 
Control vs dose I 
Dose II vs dose I 
aError line entries are MSE. 
Table f values: 
Diet f1 (1,48) = 4.0 










































If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 19--0rthogonal comparisons as tests of significance for total iron in intestinal 
mucosa, whole intestine, and liver (Table 4) 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
Control vs dose II 
Control vs dose I 










































aError line entries are MSE. 
Table f values: 
Diet f1 (1,48) = 4.0 
Dose f2 (1 ,48) = 4.0 
0.97 13.38 25 .35 
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If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
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Table 20--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) and cytochrome P-450 activity and for TBARS production in the liver (Table 5) 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
( +Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
Control vs dose II 
Control vs dose I 
Dose II vs dose I 
aError line entries are MSE. 
Table f values: 
Diet f1 (1,48) = 4.0 






















































If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 21--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) activity and TBARS production in the intestinal mucosa (Table 6) 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
Control vs dose II 
Control vs dose I 
Dose II vs dose I 
Err ora 
aError line entries are MSE. 
Table f values: 
Diet f1 (1,48) = 4.0 





























If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors . 
Table 22--0rthogonal comparisons as tests of significance for weight, hemoglobin, and 
serum iron (Table 8) 
Calculated f 
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Comparison Body Weight Hemoglobin Serum Fe 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
(+Se+Fe & -Se++Fe) 
vs 
(-Se+Fe & +Se++Fe) 
Control vs dose 
Err ora 
aError line entries are MSE. 
Table f value (alpha 0.05): 























If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 23--0rthogonal comparisons as tests of significance for iron in liver, intestinal 









+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fevs-Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
(+Se+Fe & -Se++Fe) 
vs 
(-Se+Fe & +Se++Fe) 
Control vs dose 
Err ora 
aError line entries are MSE. 
Table f value (alpha 0.05): 























If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 24--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) and cytochrome P-450 activity and for TBARS production in the liver (Table 
10). 
Calculated f 




+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
( +Se+Fe & -Se++Fe) 
vs 
(-Se+Fe $ +Se++Fe) 
Control vs dose 
aError line entries are MSE. 
Table f value (alpha 0.05): 












0.2 0.0 0.0 
0.8 0.6 68.5 
1.7 1.3 150.9 
0.2 0.4 67.5 
0.7 1.0 149.5 
0.2 0.2 16.1 
1.5 1.6 210.1 
0.4 0.1 8.3 
0.0 0.0 7.8 
0.0 0.0 1.7 
0.2 0.2 0.1 
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If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 25--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) activity and TBARS production in the intestine (Table 11). 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se++Fe 
+Se+Fe vs -Se++Fe 
-Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
( +Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
( +Se+Fe & -Se++Fe) 
vs 
(-Se+Fe & +Se++Fe) 
Control vs dose 
aError line entries are MSE. 
Table f value (alpha 0.05): 















If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
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Table 26--0rthogonal comparisons as tests of significance for fmal body weight, 





Animal Intestinal Whole 
Comparison Weight Hb mucosa intestine Liver 
-----------------------------------------------------------------------------------------------------------
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se-Fe 
+Se+Fe vs -Se-Fe 
+Se+Fe vs +Se++Fe 
-Se+Fe vs -Se++Fe 
+Se++Fe vs -Se++Fe 
(+Se+Fe & -Se+Fe) 
vs 
(+Se++Fe & -Se++Fe) 
+Se+Fe & +Se++Fe) 
vs 
(-Se+Fe & -Se++Fe) 
(+Se+Fe & +Se-Fe) 
vs 
(+Se+Fe & -Se+Fe) 
(+Se+Fe & -Se+Fe) 
vs 
(+Se-Fe & -Se-Fe) 
aError line entries are MSE. 
Table f value (alpha 0.05): 












0.14 0.02 0.02 
3.42 0.16 3.79 
0.14 0.26 3.59 
223 125 602 
141 97 536 
8.47 0.55 0.25 
226 139 716 
3.29 0.10 0.12 
0.71 0.10 1.09 
4.07 0.00 4.82 
0.37 0.54 0.81 
If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
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Table 27--0rthogonal comparisons as tests of significance for hemoglobin and serum iron 
in rats (Table 15). 
Comparison 
+Se+Fe vs -Se+Fe 
+Se+Fe vs +Se-Fe 
+Se+Fe vs -Se-Fe 
-Se+Fe vs +Se-Fe 
-Se+Fe vs -Se-Fe 
+Se-Fe vs -Se-Fe 
(+Se+Fe & -Se+Fe) 
VS 
(+Se-Fe & -Se-Fe) 
(+Se+Fe & +Se-Fe) 
vs 
(-Se+Fe & -Se-Fe) 
(+Se+Fe & -Se-Fe) 
vs 
(-Se+Fe & +Se-Fe) 
Control vs dose 
aError line entries are MSE. 
Table f value (alpha 0.05): 
Treatment f1 (1,16) = 4.49 
Calculated f 












If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
Table 28--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) and TBARS production in the liver and intestinal mucsa and for liver 




GSHPx P-450 TBARS GSHPx TBARS 
Comparison EPN para-nitroan 
-----------------------------------------------------------------------------------------------------------
+Se+Fe vs -Se+Fe 139 0.89 1.00 0.00 31.1 0.50 
+Se+Fe vs +Se-Fe 0.80 0.01 0.43 0.01 1.70 0.06 
+Se+Fe vs -Se-Fe 116 0.08 1.23 0.01 26.1 0.14 
+Se+Fe vs +Se++Fe 23.6 0.14 1.75 45.4 17.9 19.9 
-Se+Fe vs -Se++Fe 1.01 0.42 0.29 152 5.76 41.7 
+Se++Fe vs -Se++Fe 73.2 4.14 8.60 37.8 16.8 6.25 
(+Se+Fe & -Se+Fe) 
vs 10.6 0.03 0.17 115 13.7 37.9 
(+Se++Fe & -Se++Fe) 
(+Se+Fe & +Se++Fe) 
vs 131 2.75 4.77 11.4 29.7 2.23 
(-Se+Fe & -Se++Fe) 
(+Se+Fe & +Se-Fe) 
vs 53.0 0.24 0.90 0.00 15.6 0.07 
(+Se+Fe & -Se+Fe) 
(+Se+Fe & -Se+Fe) 
vs 0.52 0.43 2.64 0.01 0.70 0.24 
(+Se-Fe & -Se-Fe) 
-----------------------------------------------------------------------------------------------------------
Err ora 0.01 
aError line entries are MSE. 
Table f value (alpha 0.05): 
f (1,24) = 4.26 
0.03 0.06 0.09 0.001 0.10 
If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
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Table 29--0rthogonal comparisons as tests of significance for glutathione peroxidase 
(GSHPx) and TBARS production in the liver and intestinal mucsa and for liver 






GSHPx P-450 TBARS GSHPx TBARS 
-------------------
Comparison EPN para-nitroan 
-----------------------------------------------------------------------------------------------------------
+Se+Fe vs -Se+Fe 290 
+Se+Fe vs +Se-Fe 1.03 
+Se+Fe vs -Se-Fe 282 
-Se+Fe vs +Se-Fe 256 
-Se+Fe vs -Se-Fe 0.05 
+Se-Fe vs -Se-Fe 249 
(+Se+Fe & -Se+Fe) 
vs 0.32 
(+Se-Fe & -Se-Fe) 
(+Se+Fe & +Se-Fe) 
vs 538 
(-Se+Fe & -Se-Fe) 
(+Se+Fe & -Se-Fe) 
vs 0.76 
(-Se+Fe & +Se-Fe) 
Control vs dose 0.07 
0.01 
aError line entries are MSE. 
Table fvalue (alpha 0.05): 












0.30 0.40 12.8 1.01 
0.00 0.08 3.10 1.80 
0.20 0.16 10.1 0.00 
0.30 0.82 28.4 0.11 
1.00 1.05 0.16 0.94 
0.20 0.01 24.3 1.71 
0.50 0.85 2.34 0.07 
0.00 0.13 36.2 0.05 
0.50 0.28 0.92 2.67 
1.30 1.07 4.25 3.93 
0.15 0.00 0.002 0.21 
If any calculated f is higher than the respective table f value, there is a significant difference 
between the compared factors. 
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